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ABSTRACT 
The Folding and Binding Partners of the Perlecan SEA Module 
by 
Ariel Diaz 
Sperm protein, enterokinase and agrin (SEA) modules are small folds within 
large heavily glycosylated modular proteins.  Because decreased expression of SEA-
containing proteins such as perlecan (PLN) can lead to diseases such as Schwartz-
Jampel syndrome (SJS), characteristics of the PLN SEA module including folding, 
potential for autocleavage, and protein binding were studied.  Sequence analyses, 
recombinant protein evaluation, and a yeast two-hybrid screen were used to study 
the PLN SEA module and compare it to the mucin (MUC) 1 SEA module.  In silico 
modeling of the PLN SEA module demonstrated a well conserved α/β sandwich fold.  
Experiments with expressed proteins showed that unlike MUC1, the PLN SEA 
module does not autocleave. Two-hybrid screening identified four “high confidence” 
proteins as potential binding partners which were explored in preliminary 
experiments.   Together, these results demonstrate that PLN SEA module is unique 
and its properties cannot be generalized with other SEA module proteins such as 
MUC1.  
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Chapter 1 
Introduction and review 
SEA modules are modular folds found in highly glycosylated extracellular 
proteins whose functionality is poorly understood.  They are small modules, 
consisting of approximately 120 amino acids.  SEA modules are conserved in species 
ranging from nematodes to humans, suggesting that they have a conserved, but yet 
unknown, function (Bork and Patthy, 1995).  Some SEA modules autocleave during 
cellular processing leaving the parent protein as two associated but not bound 
moieties (Khatri et al., 2003).  The purpose of an SEA module’s autocleavage is 
unknown but has been linked to trafficking, shedding, and compositional 
determination.  Here I examined the PLN SEA module specifically.  PLN is an 
extracellular matrix (ECM) protein ubiquitously expressed, that is an essential 
component of the basement membrane (BM) and various other territorial matrices 
surrounding cells (Noonan and Hassell, 1993).  In instances where PLN secretion is 
 3 
decreased, devastating diseases such as Dyssegmental dysplasia Silverman-
Handmaker type and its milder counterpart Schwartz-Jampel syndrome (SJS) can 
result (OMIM, 2011).  If the SEA module does indeed play a role in the trafficking of 
parent proteins through the secretory pathway, then a better understanding of the 
SEA module structure and its interactions with other proteins can provide insight 
into various ways of assessing diseases associated with PLN insufficiency. 
1.1. Background 
1.1.1. SEA modules 
SEA modules were first identified in a 63-kDa sea urchin sperm protein, 
enterokinase (ENTK), and in another protein, agrin, giving rise to the acronym name 
(Bork and Patthy, 1995).  SEA modules are typically 120 amino acids long and form 
a modular domain in glycosylated proteins.  Most SEA module proteins only contain 
one SEA, a few contain two SEAs, and one protein, MUC16 , contains many SEA 
modules (Bork and Patthy, 1995; Maeda et al., 2004; Bandah-Rozenfeld et al., 2010).  
In membrane bound SEA-containing proteins, the module is found proximal to the 
cell surface. 
1.1.1.1. Structure 
The folding domain is composed of two primary alpha helices and three or 
four antiparallel beta strands that form an α/β sandwich fold or heart shaped  
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Figure 1– SEA module solution structures. 
The arrow indicates the linker region between the β2 and the β3 strand.   A) SEA 
domain from the murine MUC16 using solved using multi-dimensional NMR.  The 
ribbon representation is of the of the lowest energy structure. The linker  between 
β2 and the β3 strands is long and this module is not known to autocleave. B) Human 
MUC1 SEA module.  The cleavage site is between the β2 and the β3 strand. The 
linker  between β2 and the β3 strands is short and this module is known to 
autocleave. (Maeda et al., 2004 and Macao et al., 2006.) 
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Figure 2 - Autocleavage mechanism in the MUC1 SEA. 
Conformational strain on the loop between the second and third β strand from 
folding increases the proximity of the glycine and serine.  This aides in the 
rearrangement reaction need to produce an ester.  A hydrolysis reaction then breaks 
the protein into two subunits.  (Levitin et al., 2005) 
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domain (Maeda et al., 2004; Macao et al., 2006).  The first solution structure for an 
SEA module was one of the SEAs in the murine MUC16 (Protein Data Bank (PDB) ID 
– 1IVZ) (Figure 1) (Maeda et al., 2004).  The overall fold was confirmed with the 
solution structure of the human MUC1 SEA module (PDB ID 2ACM) (Figure 1) 
(Macao et al., 2006).  A third unpublished solution structure for the SEA of a 
transmembrane protease from Mus musculus is also in the PDB (PDB ID 2E7V). 
1.1.1.2. Functional Studies 
Thus far, there is no determined function of an SEA module; there are only 
implied ones.  Some suggested functions include a role in trafficking, shedding, and 
compositional determination (Parry et al., 2001; Wreschner et al., 2002; Lillehoj et 
al., 2003).  The fact that SEA modules are found in highly glycosylated proteins 
suggests a potential role in mediating the passage of the protein through the 
secretory pathway, but this has not been demonstated.  It is intriguing to suggest 
that SEA module interactions could facilitate the glycosylation of SEA module 
containing proteins either by reducing their rate of transit through the Golgi by 
controlling vesicle budding and progress through the secretory pathway so that 
carbohydrates can be added, or by stabilizing a conformation of the protein or 
protein complex that would increase access to the glycoslyation machinery. 
The MUC1 SEA module autocleaves at a G-SVVV autocleavage motif during 
intracellular processing creating the two (α and β) subunits of the protein (Parry et 
al., 2001; Levitin et al., 2005; Macao et al., 2006).  Autocleavage in the MUC1 SEA 
 7 
has been determined to be a two-step process (Levitin et al., 2005).  First an N to O 
acyl shift, which is aided by conformational strain, creates an ester (Figure 2).  This 
is then cleaved through a hydrolysis reaction resulting in two subunits of the 
protein (Figure2).  This mechanism highlights the importance of the serine in the 
autocleavage motif.  One study has shown that a threonine or a cysteine but no other 
amino acid in place of the serine also allows for cleavage (Macao et al., 2006).  The 
cleavage event of the SEA module in Ig-Hepta and dystroglycan (DAG1), was found 
to occur in the endoplasmic reticulum (ER) and remain non-covalently associated 
(Abe et al., 2002; Wreschner et al., 2002).  When the serine in the G-SVVV motif of 
the MUC1SEA was mutated to an alanine, it blocked cleavage and reduced the 
amount of shedding (Lillehoj et al., 2003).  Blocking cleavage also enhances the 
functional glycosylation of DAG1, an ECM receptor, which increases its ability to 
bind laminin (Wreschner et al., 2002).  Other data suggests that SEA modules are 
required for optimal biological activity in MUC3 and MUC17 (Ho et al., 2010).  These 
data point to a functional role for the SEA in the parent protein with an emphasis on 
the autocleavage of the SEA module being important to its function. 
1.1.2. Perlecan 
PLN is a modular, highly glycosylated SEA module containing heparan sulfate 
proteoglycan that is fully secreted into the ECM and plays an important role as a 
barrier, in development, and in tumorigenesis.  Human PLN is 4,391 amino acids 
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long with a core protein that weighs approximately 450kDa.  The size can be much 
larger depending on the amount of glycosaminoglycan (GAG) additions.   
1.1.2.1. Structure 
PLN has five domains (I-V) (Figure 3) (Murdoch et al., 1992).  Domain I 
contains three heparan sulfate (HS) and/or chondroitin sulfate attachment sites and  
an SEA module (Murdoch et al., 1992; Noonan and Hassell, 1993; Kokenyesi and 
Silbert, 1995; Costell et al., 1997; Dolan et al., 1997; Sasaki et al., 1998; Friedrich et 
al., 1999; Tapanadechopone et al., 1999).  Domain I does not share homology with 
other domains in PLN (Murdoch et al., 1992).  Human PLN domain II contains four 
low-density lipoprotein (LDL) receptor-like modules and one immunoglobulin G 
(IgG)-like repeat (Murdoch et al., 1992; Noonan and Hassell, 1993).  Human PLN 
domain III is a rigid domain that contains three laminin domain IV-like modules and 
eight epidermal growth factor (EGF)-like repeats.  Human PLN domain IV is a large 
flexible domain.  It is the largest of the five domains and has 21 IgG-like repeats.  
Human PLN domain V has three globular domains of laminin alpha-chains like 
modules and four EGF-like repeats (http://www.genecards.org/cgi-
bin/carddisp.pl?gene=HSPG2&search=perlecan). 
1.1.2.2. Function 
PLN is found in bone marrow, soft tissue organs, the vasculature, and muscle 
tissue (Murdoch et al., 1992; French et al., 1999; Schofield et al., 1999; Melrose et 
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al., 2006).  It functions as a component of the BM, binds growth factors through its 
GAG chains, and is involved in cell signaling (Hassell et al., 1980; Sasaki et al., 1998; 
Hopf et al., 1999; Kvansakul et al., 2001).  Perlecan helps provide an anchor for 
tissues and a boundary between tissues as an element of the basement membrane.  
It maintains the endothelial barrier as a part of the vascular ECM surrounding blood 
vessels.  PLN is also critical to the function of the glomerular BM, a size- and charge-
selective barrier.  As a large multidomain protein it binds and cross-links ECM 
components and cell-surface molecules.  It binds or interacts with nidogen-2, 
laminin , fibulin-2, prolargin, fibronectin, PRELP (proline/arginine-rich and leucine-
rich repeat protein)/prolargin, types IV, XIII, and XVIII collagen, transthyretin and 
FGF-1, -2, -7, and -9 (Sasaki et al., 1995; Smeland et al., 1997; Ettner et al., 1998; 
Kohfeldt et al., 1998; Chang et al., 2000; Mongiat et al., 2000; Clayton et al., 2001; 
Ghiselli et al., 2001; Hopf et al., 2001; Bengtsson et al., 2002; Tu et al., 2002; 
Salmivirta et al., 2002; Miosge et al., 2003).  A fragment of PLN domain V called 
endorepellin has anti tumorigenic activity by blocking neovascularization (Mongiat 
et al., 2003; Bix et al., 2004, 2006; Fjeldstad and Kolset, 2005; Goyal et al., 2011). 
1.1.2.3. Pathologies 
PLN acts as a boundary and when its barrier function fails, development can 
be compromised and tissue quality can become altered (Figure 4) and it can allow 
cancer cell invasion (Costell et al., 1999).  Homozygous mice with a null mutation  
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Figure 3– Perlecan schematic. 
PLN has five domains,I-V.  Domain I contains three HS attachment (red lines) sites 
and an SEA module (brown box).  Human PLN domain II contains four LDL receptor-
like modules and 1 IgG-like repeat.  Human PLN domain III contains three laminin 
domain IV-like modules (purple pentagons) and eight EGF-like repeats (green 
squares).  Domain IV has 21 IgG-like repeats .  Domain V has three globular domain 
of laminin alpha-chains like modules (blue hexagons) and four EGF-like repeats 
(orange pentagons). (Modified from Farach-Carson et al., 2007) 
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Figure 4 – Perlecan in mammals. 
A) Developing mouse embryo with normal PLN expression.  B) PLN-deficient 
embryos showing blood leakage into the pericardial cavity due to a deterioration of 
BMs.  C) In normal brain, the neuroepithelium and the overlying mesenchyme are 
separated by a BM.  D) Without the PLN barrier, the neuroepithelial cells invade the 
overlying ectoderm (arrow) which can lead to I) a loss of the roof of skull and 
exencephaly.  C) chondro-osseous junction in a mouse hindlimb. Anti-PLN (red) in 
the matrix is a strong boundry between the periosteum (Po) and perichondrium 
(Pc).  Heparanase immunostaining is green.  The yellow line indicates the boundary 
between the developing bone and mineralized bone.  (Modified from Costell et al., 
1999 and Brown et al., 2008) 
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F 
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for PLN can create rudimentary BMs, but they deteriorate (Costell et al., 1999; Sasse 
et al., 2008).  PLN is also present at a key boundary in the bone, the chondro–
osseous junction (Figure 4) (Brown et al., 2008).  Research models with insufficient 
PLN secretion in the bone resemble the a chondrodysplasia disorder, SJS, 
characterized by reduced stature, deformed joints, pigeon breast, and other skeletal 
defects (Aberfeld et al., 1965; Giedion, 1997; Spranger et al., 2000; Rodgers et al., 
2007).  Another example of the negative effect of the breakdown of PLN is in the 
kidney.  When PLN is destroyed in the kidney, the filtering properties of the 
glomerular BM are altered and cause proteinuria (Miettinen et al., 1986;Morita et 
al., 2005).  Understanding the role the PLN SEA domain plays in PLN secretion may 
provide insight into SJS and perhaps find new avenues for therapy. 
1.1.3. Secretory Pathway and SEA proteins 
A common feature of SEA module proteins is that they are glycosylated 
requiring them to enter the ER and proceed through the secretory pathway.  The 
two proteins studied here have signal sequences that target them to the ER for 
processing and glycosylation.  Human PLN’s signal sequence is 
MGWRAAGALLLALLLHGRLLA and human MUC1’s signal sequence is 
MTPGTQSPFFLLLLLTVLTVVTG (Parry et al., 2001).  The high number of 
hydrophobic residues in these signal sequence are typical of those that target 
proteins to the ER.  While in the ER some SEA modules autocleave and this action 
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may be a check point for continued processing or an event that subsequently alters 
the composition of the carbohydrates added to the protein in the Golgi complex 
(Abe et al., 2002a; Wreschner et al., 2002).  SEA module containing proteins are 
brought to the cell surface where they are either fully secreted to the extracellular 
environment or inserted into the membrane as highly glycosylated membrane 
bound extracellular proteins after successful transit through the Golgi and 
glycosylation.
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Chapter 2 
Structural aspects of the Perlecan SEA 
module 
The PLN SEA is an 115 amino acid module found in the first domain of the 
protein, following the three glycosaminoglycan (GAG) chain attachment sites (Bork 
and Patthy, 1995).  I examined structural aspects of the SEA module alone and in 
comparison to other known SEA modules.  Sequence analyses were performed to 
determine consensus across a large group human SEAs as well as a narrower subset 
of SEA containing proteins across species.  The PLN SEA was further compared to 
the MUC1 SEA, the most well studied SEA module.  Protein folding comparisons 
were made with established structures and predicted structures.  Similarities in 
parts of the sequence and structure inspired autocleavage analysis of the PLN SEA.  
Further sequence analysis after autocleavage studies lead to predictions of 
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autocleavage characteristics in unstudied proteins.  Finally residues were identified 
that may be responsible for cleavage or binding to other proteins. 
2.1. Sequence analysis of SEA modules 
An initial amino acid sequence conservation analysis was performed to 
examine human proteins containing SEA modules using Geneious software v5.3.6 
(Auckland, New Zealand).  The analysis had a pairwise identity of 13.7%.  There was 
a marked difference in the region of conservation when comparing protein 
sequences (Figure 5).  The first half of the protein shows a higher level of 
conservation with little to no conserved residues in the second half of the 
conservation analysis. 
Examining further into the amino acid conservation, I performed another 
analysis using a smaller subset of SEA proteins that previously had been categorized 
to have a shared fundamental function or a similar target molecule (Maeda et al., 
2004).  I compared the SEA modules from PLN human and mouse; MUC3A human; 
MUC3B human; MUC1 mouse, hamster, gibbon, human, and cow; and ENTK pig, 
mouse, human, and cow.  The level of conservation is higher, at 22.8% pairwise 
identity, than in the first analysis.  This analysis maintains similar regions of 
conservation with the first half of the module showing a higher degree of 
conservation than the rest of the amino acid sequence (Figure 6).  Interestingly the 
MUC1 SEA autocleavage motif is also very highly conserved, suggesting that the PLN 
SEA may also autocleave.   
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Figure 5 - Protein sequence alignment of human SEA modules. 
Geneious alignment with a Blosum62 cost matrix and an exception of 1.  Highlighted 
residues have at least a 25% consensus across the sequence alignment.  SEAs in this 
alignment include AGRIN,ENTK, GP110, GP116, IMPG1, IMPG2, MUC1, MUC3A, 
MUC3B, MUC12, MUC13, PLN, TM11A, TM11B, TM11D, TM11E, TM11F, and UROL1. 
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Figure 6 - Protein sequence alignment of SEA modules from similar protein families 
from different species.   
Alignment method the same as in figure 4. Highlighted residues have at least a 25% 
consensus across the sequence alignment.  SEAs include ENTK, GP110, GP116, 
IMPG1 (2 of 2), IMPG2 (2 of 2), MUC1, MUC3A, MUC3B, MUC12, MUC17, PLN and 
UROL1 of various species. 
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The MUC1 SEA module G-SVVV autocleavage motif has been highly studied.  
Previous studies have shown that an autocleavage event occurs between the glycine 
and the serine during protein processing in the ER creating two associated but non-
covalently bound pieces of the SEA module (Parry et al., 2001; Wreschner et al., 
2002; Abe et al., 2002b; Khatri et al., 2003; Lillehoj et al., 2003; Maeda et al., 2004; 
Levitin et al., 2005; Palmai-Pallag et al., 2005; Macao et al., 2006).  While previous 
studies have shown that some sequence specificity is important in this cleavage 
event, other have studies shown that the overall fold of the module is crucial in 
creating enough strain on the sequence to cause the break in the peptide back bone 
(Levitin et al., 2005; Macao et al., 2006).  In figure 1 the αβ sandwich fold is 
maintained if both the murine MUC16 SEA and the human MUC1 sea.  Not shown in 
the figure is the structure for the murine transmembrane protease SEA module 
which also folds in an αβ sandwich.  The autocleavage motif in PLN is maintained 
with the exception of the serine and the valine.  Instead its sequence reads GWVFV.  
This maintenance of the autocleavage motif could suggest an autocleavage event in 
the PLN SEA module. 
2.2. Folding predictions for the Perlecan SEA module 
Often the function of a protein domain is determined by its fold.  In an effort 
to better understand the function and the role of the PLN SEA module, folding 
predictions were made using the Phyre2 program (Kelley and Sternberg, 2009).  
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Phyre2 returned 46 possible modeling templates (Table 1).  The alignment guided 
structure prediction modeled the PLN SEA after the SEA module of the 
transmembrane protease 11D from Mus musculus (PDB ID– 2E7V) the template with 
the highest confidence.  This folding prediction shows three beta strands and two 
primary alpha helices (Figure 7). 
Similar folding patterns often have similar functions or characteristics and so 
the PLN SEA module folding prediction was compared to the more studied MUC1 
SEA module that autocleaves.  The fold of the MUC1 SEA module has been 
previously determined and maintains the α/β sandwich conformation with four 
antiparallel beta strands and two alpha helices (Figure 7) (Maeda et al., 2004).   
2.3. Characterization of recombinant SEA modules 
To study the physical characteristic of the protein, I recombinantly produced 
it in BL21 Escherichia coli.  Previous SEA module work has been performed with 
bacterially produced proteins, I wanted to avoid differences that may have arisen 
from glycosylation if expressed in mammalian cells (Levitin et al., 2005).  The MUC1 
SEA module was used as a control for all experiments because it is the most well 
studied SEA module.  Two expression constructs were made for each of the SEA 
modules using the inducible pET300/NT-DEST and pET301/CT-DEST destination 
vectors (Life technologies) that add a 6X histidine (HIS) tag to the ends of the 
protein for isolation and detection purposes.  The protein was tagged separately at  
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PLN_SEA Modeling Templates 
    
 
# Template  Confidence 
% 
i.d.  
Template Information 
1 c2e7vA 85.6 15 
PDB header:hydrolase 
Chain: A: PDB Molecule:transmembrane 
protease; 
PDBTitle: crystal structure of sea domain of 
transmembrane protease2 from mus musculus 
2 d1ivza 50.6 17 
Fold:Ferredoxin-like 
Superfamily:SEA domain 
Family:SEA domain 
3 c1zcoA 46.2 20 
PDB header:lyase 
Chain: A: PDB Molecule:2-dehydro-3-
deoxyphosphoheptonate aldolase; 
PDBTitle: crystal structure of pyrococcus 
furiosus 3-deoxy-d-arabino-2 heptulosonate 7-
phosphate synthase 
4 c2a40F 41.7 47 
PDB header:structural protein 
Chain: F: PDB Molecule:wiskott-aldrich 
syndrome protein family member 2; 
PDBTitle: ternary complex of the wh2 domain of 
wave with actin-dnase i 
5 c2a40C 41.7 47 
PDB header:structural protein 
Chain: C: PDB Molecule:wiskott-aldrich 
syndrome protein family member 2; 
PDBTitle: ternary complex of the wh2 domain of 
wave with actin-dnase i 
6 d2hgsa1 34.4 37 
Fold:PreATP-grasp domain 
Superfamily:PreATP-grasp domain 
Family:Eukaryotic glutathione synthetase, 
substrate-binding domain 
7 c3neuA 28.9 15 
PDB header:structural genomics, unknown 
function 
Chain: A: PDB Molecule:lin1836 protein; 
PDBTitle: the crystal structure of a functionally-
unknown protein lin1836 from2 listeria innocua 
clip11262 
8 d2p02a1 22.4 24 
Fold:S-adenosylmethionine synthetase 
Superfamily:S-adenosylmethionine synthetase 
Family:S-adenosylmethionine synthetase 
9 c1qb3B 18.7 41 
PDB header:cell cycle 
Chain: B: PDB Molecule:cyclin-dependent 
kinases regulatory subunit; 
PDBTitle: crystal structure of the cell cycle 
regulatory protein cks1 
10 d1qb3a 18.5 41 
Fold:Cell cycle regulatory proteins 
Superfamily:Cell cycle regulatory proteins 
Family:Cell cycle regulatory proteins 
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11 c2hgsA 18.4 37 PDB header:amine/carboxylate ligase 
Chain: A: PDB Molecule:protein (glutathione 
synthetase); 
PDBTitle: human glutathione synthetase 
12 c2di3A 16.7 20 
PDB header:transcription 
Chain: A: PDB Molecule:bacterial regulatory 
proteins, gntr family; 
PDBTitle: crystal structure of the transcriptional 
factor cgl29152 from corynebacterium 
glutamicum 
13 d3c7bb2 13 18 
Fold:Ferredoxin-like 
Superfamily:Nitrite/Sulfite reductase N-terminal 
domain-like 
Family:DsrA/DsrB N-terminal-domain-like 
14 d1mxaa1 12.9 23 
Fold:S-adenosylmethionine synthetase 
Superfamily:S-adenosylmethionine synthetase 
Family:S-adenosylmethionine synthetase 
15 c2wfoA 12.6 24 
PDB header:viral protein 
Chain: A: PDB Molecule:glycoprotein 1; 
PDBTitle: crystal structure of machupo virus 
envelope glycoprotein2 gp1 
16 d1qm4a1 11.5 21 
Fold:S-adenosylmethionine synthetase 
Superfamily:S-adenosylmethionine synthetase 
Family:S-adenosylmethionine synthetase 
17 d1m0wa1 11.5 35 
Fold:PreATP-grasp domain 
Superfamily:PreATP-grasp domain 
Family:Eukaryotic glutathione synthetase, 
substrate-binding domain 
18 d2vv5a2 10.7 27 
Fold:Ferredoxin-like 
Superfamily:Mechanosensitive channel protein 
MscS (YggB), C-terminal domain 
Family:Mechanosensitive channel protein MscS 
(YggB), C-terminal domain 
19 c2ky5A 10.3 43 
PDB header:cell adhesion 
Chain: A: PDB Molecule:platelet endothelial cell 
adhesion molecule; 
PDBTitle: solution structure of the pecam-1 
cytoplasmic tail with dpc 
20 c3kalB 10.1 35 
PDB header:ligase 
Chain: B: PDB Molecule:homoglutathione 
synthetase; 
PDBTitle: structure of homoglutathione 
synthetase from glycine max in2 closed 
conformation with homoglutathione, adp, a 
sulfate3 ion, and three magnesium ions bound 
21 c1y7xA 9.8 21 
PDB header:structural protein, protein binding 
Chain: A: PDB Molecule:major vault protein; 
PDBTitle: solution structure of a two-repeat 
fragment of major vault2 protein 
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22 c1xbsA 9.7 20 
PDB header:transcription, cell cycle 
Chain: A: PDB Molecule:dim1-like protein; 
PDBTitle: crystal structure of human dim2: a 
dim1-like protein 
23 c3t4cD 9.3 12 
PDB header:transferase 
Chain: D: PDB Molecule:2-dehydro-3-
deoxyphosphooctonate aldolase 1; 
PDBTitle: crystal structure of 2-dehydro-3-
deoxyphosphooctonate aldolase from2 
burkholderia ambifaria 
24 d1r26a 9.2 14 
Fold:Thioredoxin fold 
Superfamily:Thioredoxin-like 
Family:Thioltransferase 
25 c1m0tB 8.4 35 
PDB header:ligase 
Chain: B: PDB Molecule:glutathione synthetase; 
PDBTitle: yeast glutathione synthase 
26 c3ic7A 8 7 
PDB header:structural genomics, unknown 
function 
Chain: A: PDB Molecule:putative transcriptional 
regulator; 
PDBTitle: crystal structure of putative 
transcriptional regulator of gntr family2 from 
bacteroides thetaiotaomicron 
27 c2y75F 7.7 15 
PDB header:transcription 
Chain: F: PDB Molecule:hth-type transcriptional 
regulator cymr; 
PDBTitle: the structure of cymr (yrzc) the global 
cysteine regulator2 of b. subtilis 
28 c3kfwX 7.5 10 
PDB header:structural genomics, unknown 
function 
Chain: X: PDB Molecule:uncharacterized protein; 
PDBTitle: uncharacterized protein rv0674 from 
mycobacterium tuberculosis 
29 c1cffB 7.4 50 
PDB header:calmodulin 
Chain: B: PDB Molecule:protein (calcium pump); 
PDBTitle: nmr solution structure of a complex of 
calmodulin with a2 binding peptide of the ca2+-
pump 
30 c3eetA 7.4 16 
PDB header:transcription regulator 
Chain: A: PDB Molecule:putative gntr-family 
transcriptional regulator; 
PDBTitle: crystal structure of putative gntr-
family transcriptional2 regulator 
31 c2i7fB 7.1 20 
PDB header:oxidoreductase 
Chain: B: PDB Molecule:ferredoxin component of 
dioxygenase; 
PDBTitle: sphingomonas yanoikuyae b1 
ferredoxin 
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32 c3fhkF 7.1 19 PDB header:structural genomics, unknown 
function 
Chain: F: PDB Molecule:upf0403 protein yphp; 
PDBTitle: crystal structure of apc1446, b.subtilis 
yphp disulfide2 isomerase 
33 d2r7ca2 7 27 
Fold:Rotavirus NSP2 fragment, N-terminal 
domain 
Superfamily:Rotavirus NSP2 fragment, N-
terminal domain 
Family:Rotavirus NSP2 fragment, N-terminal 
domain 
34 c1g5vA 6.6 17 
PDB header:translation 
Chain: A: PDB Molecule:survival motor neuron 
protein 1; 
PDBTitle: solution structure of the tudor domain 
of the human smn2 protein 
35 d1lvaa3 6.6 23 
Fold:DNA/RNA-binding 3-helical bundle 
Superfamily:"Winged helix" DNA-binding 
domain 
Family:C-terminal fragment of elongation factor 
SelB 
36 c1trlB 6.4 25 
PDB header:hydrolase (metalloprotease) 
Chain: B: PDB Molecule:thermolysin fragment 
255 - 316; 
PDBTitle: nmr solution structure of the c-
terminal fragment 255-3162 of thermolysin: a 
dimer formed by subunits having the3 native 
structure 
37 c2gu0A 6.4 33 
PDB header:viral protein 
Chain: A: PDB Molecule:nonstructural protein 2; 
PDBTitle: crystal structure of human rotavirus 
nsp2 (group c /2 bristol strain) 
38 c3pnwX 6.2 50 
PDB header:protein binding/immune system 
Chain: X: PDB Molecule:tudor domain-containing 
protein 3; 
PDBTitle: crystal structure of the tudor domain 
of human tdrd3 in complex with2 an anti-tdrd3 
fab 
39 c2d9tA 6 50 
PDB header:structural genomics, unknown 
function 
Chain: A: PDB Molecule:tudor domain-
containing protein 3; 
PDBTitle: solution structure of the tudor domain 
of tudor domain2 containing protein 3 from 
mouse 
40 d1mhna 6 17 
Fold:SH3-like barrel 
Superfamily:Tudor/PWWP/MBT 
Family:Tudor domain 
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41 d1fe0a 6 13 Fold:Ferredoxin-like 
Superfamily:HMA, heavy metal-associated 
domain 
Family:HMA, heavy metal-associated domain 
42 c1vs1B 5.7 26 
PDB header:transferase 
Chain: B: PDB Molecule:3-deoxy-7-
phosphoheptulonate synthase; 
PDBTitle: crystal structure of 3-deoxy-d-
arabino-heptulosonate-7-2 phosphate synthase 
(dahp synthase) from aeropyrum pernix3 in 
complex with mn2+ and pep 
43 d1wy6a1 5.7 21 
Fold:alpha-alpha superhelix 
Superfamily:Hypothetical protein ST1625 
Family:Hypothetical protein ST1625 
44 c4a4fA 5.6 17 
PDB header:rna binding protein 
Chain: A: PDB Molecule:survival of motor 
neuron-related-splicing factor 30; 
PDBTitle: solution structure of spf30 tudor 
domain in complex with2 symmetrically 
dimethylated arginine 
45 d1ldda 5.3 16 
Fold:DNA/RNA-binding 3-helical bundle 
Superfamily:"Winged helix" DNA-binding 
domain 
Family:SCF ubiquitin ligase complex WHB 
domain 
46 d1knwa1 5.2 30 
Fold:Domain of alpha and beta subunits of F1 
ATP synthase-like 
Superfamily:Alanine racemase C-terminal 
domain-like 
Family:Eukaryotic ODC-like 
 
 
 
 
 
 
 
 
 
Table 1 – Phyre2 results for the PLN SEA module. 
Phyre2 returned proteins that could be used as a template for modeling the PLN 
SEA module.  Each protein is listed by its PDB id, given a confidence score, the 
percent of matching protein sequence is listed, and some descriptive information.     
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Figure 7 – SEA module folding. 
Structures are displayed in the NewCartoon style with VMD software.  Individual 
residues are highlighted as beads.  A) Predicted folding of PLN SEA module by 
Phyre2 base on PDB structure 2E7V.  Residues 62-67 (GWVFV) of the SEA are 
highlighted, corresponding to residues 142 – 146 of PLN. B) MUC1 SEA folf (PDB 
2ACM).  Residues 64 – 68 (GSVVV) are highlighted.  These correspond to residues 
1097 – 1011 of MUC1. 
A   Human PLN SEA 
B   Human MUC1 SEA 
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either end so that both fragments could be detected in the event of autocleavage.  
The protein of interest was extracted from cell lysates by metal ion 
chromatography.  Samples from both the whole cell lysate and purified protein were 
analyzed.   
Protein production was confirmed by Coomassie staining of pre and post 
induction samples of whole cell lysates on sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) gels (Figure 8).  The arrows indicate new protein 
bands in the post induction sample not found in the pre induction sample.  The 
strength of the post induction bands indicates very high abundance of recombinant 
protein produced by the cultures.  Purified protein was then dialyzed into elution 
buffers with pHs ranging from five to eight to examine the stability of the 
recombinant protein.  There was no change from sample to sample across all the 
pHs tested (Figure 9).  None of the samples showed new bands at smaller than 
expected sizes that would indicate a pH dependent autocleavage. 
2.3.1. Perlecan SEA module autocleavage analysis 
SEA module autocleavage analysis was initially examined by Coomassie 
staining of whole cell lysates on gradient SDS-PAGE gels (Figure 8).  The new band 
in the post induction sample for the N-terminally tagged PLN (PN) SEA module is 
approximately 14kDa, the same size as the predicted weight of the full length PLN 
SEA.  The results were not repeated for the C-terminally tagged PLN (PC) SEA.  The 
new band in the post induction sample was approximately 28kDa, which is neither 
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the size of the full length or the cleaved protein.  This band is twice the size of the 
expected protein.  Sequencing the expression plasmid to verify that only one copy of 
the SEA module is present would eliminate one possible reason for the presence of 
this 28kDa band.  Similarly inconclusive results were seen in the expressed MUC1 
SEA-module samples (Data not shown). 
To obtain more conclusive autocleavage information, western blots were 
performed on the purified proteins (Figure 10).  The PLN SEA was detected at 
approximately 14kDa, similar to the initial Coomassie result and matching the 
expected size of the full length protein.  If the PLN SEA were cleaved a band would 
have been detected at about half the size.  The MUC1 SEA was detected at 
approximately 7kDa.  This size fragment matches results from previous studies 
showing that the MUC1 SEA autocleaves approximately in the middle of the 
sequence at the G-SVVV autocleavage motif (Levitin et al., 2005).   The upper three 
bands are likely bacterial protein because they are found in both samples.  To clarify 
this, the antibody should be tested on bacterial whole cell lysate to see if the same 
bands are found in uninduced unpurified protein samples. 
Models of small pieces of each protein containing the autocleavage motif 
were made to better understand the differences in autocleavage results.  The Phyre2 
program (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) was used 
and returned a number of possible templates for each protein (Table 2 and 3).  Only 
the template with the highest confidence was used to create the model. The MUC1  
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Figure 8 - Coomassie staining of pre and post induction samples. 
Whole  cell lysates  from recombinant protein producing  bacterial cultures  were 
electrophoresed on gradient SDS-PAGE gels.  This gel both confirms production and 
indicates the size of the recombinant proteins.  PN recombinant protein in the post 
induction sample is detected as a 14kDa band.  PC recombinant protein is detected 
as a 28kDa band in the post induction sample. The abundance of both recombinant 
protein is very high. 
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Figure 9 – pH stability of recombinant protein PN. 
Purified protein PN was dialyzed into elution buffers (50mM NaH2PO4, 300mM NaCl 
and 300mM imidazole) of different pHs and maintained for 16 hours at 4°C.  
Samples of each were electrophoresed on gradient SDS-PAGE gels and Coomassie 
stained.  The arrow indicates the expected protein size.  No band is detected at a 
smaller then expected size in any of the samples.   
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Figure 10 – Western blot autocleavage analysis. 
Purified recombinant proteins were electrophoresed on a NuPAGE® Novex® 4-
12% Bis-Tris gradient SDS-PAGE gel in MOPS running buffer.  The primary antibody 
was an anti-HIS mouse monoclonal antibody(Qiagen) and the secondary antibody 
wand and anti-mouse HRP antibody (BioRad).  MUC1 SEA recombinant protein 
detected as a 6kDa band. PLN SEA  recombinant protein is detected as a 14kDa 
band.   Larger protein bands are likely bacterial proteins as they are detected in both 
samples. 
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structure (PDB ID – 2ACM) was used in the modeling of the sequence surrounding 
and including the autocleavage motif for MUC1.  The confidence in this model was 
high at 97.2.  The MUC1 model shows a tight turn just before the autocleavage motif 
between the two beta strands (Figure 11).  This tight turn is what has been shown 
to be necessary to place enough steric strain on the peptide backbone to cause 
autocleavage (Macao et al., 2006).  The PLN autocleavage motif was model using the 
putative transcription anti-termination protein NusG (PDB ID – c3ewgA) as the 
template.  The confidence in this model is low at 28.3.  The PLN SEA model shows a 
much longer loop between the two strands and preceding the GWVFV sequence 
(Figure 11). 
2.4.  Autocleavage predictions 
In an attempt to make autocleavage predictions on unstudied proteins a 
sequence analysis was performed on the SEA modules that are known to autocleave; 
DAG1, G-protein coupled receptor 116 (GP116), MUC1, MUC3A, MUC3B, MUC12, 
and TMPRSS6.  A sequence analysis was performed and only the residues that were 
100% conserved were noted (Figure 12).  The analysis showed a 24.8% matching 
sequencing identity.  Three residues were identified from the alignment; F22, G70, 
and S71.  The phenylalanine is not associated with any region of the SEA of interest 
thus far.  The glycine and serine are those of the autocleavage motif.  SEA sequences 
that are known to autocleave were analyzed by Phyre2 to see where the 
phenylalanine identified by sequence alignment is located in the folded protein.  The 
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phenylalanine is located next to the glycine and the serine of the autocleave region 
(Figure 13).    While the phenylalanine would not seem to directly participate in the 
reactions depicted in figure 2, it may press on the autocleavage motif, increasing the 
strain on the loop between the β2 and β3 strands, indirectly aiding in autocleavage.  
Using the criteria of having a phenylalanine that aligns with the one identified in 
figure 12 and having both the glycine and the serine of the autocleavage motif 
predictions were made as to which SEA will autocleave and which ones will not 
(Table 4). 
2.5. Identification of residues potentially involved in SEA 
binding 
I chose to focus on the hydrophobic residues and the potential for binding 
pocket on the SEA module.  In collaboration with another graduate student at Rice 
University, Drew Bryant (Department of Computer Science), a ClustalW sequence 
alignment and identified a number of highly conserved residues (Data not shown) 
(Thompson et al., 1994).  These residues are noted on my alignment in figure 6.  The 
residues identified were mapped to a space filling model of the MUC1 SEA (Figure 
14).  The residues were reduced to only those that are solvent facing.  The residues 
identified were F21, L25, L36, L43, L44, F60, and F68 of the sequence alignment and 
consensus sequence.  These residue locations map to Y17, L21, V32, T39, L40, V52, 
and E50 of the PLN SEA module sequence.  The residues cluster in two different 
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areas of the SEA module and are not evenly distributed.  One of the hydrophobic 
pockets is located near the MUC1 autocleavage site as noted in the 180° view. 
2.6. Materials and Methods 
2.6.1. Sequence analysis 
Proteins with accessions numbers, O00468, P98072, P98073, P97435, 
P98074, Q5T601, Q8VEC3, Q8IZF2, Q9WVT0, Q9GMS5, Q17R60, Q8R1W8, Q9ET62, 
Q1XI86, Q9BZV3, Q80XH2, P70628, Q8WML4, P15941, Q29435, Q60528, Q02496, 
Q02505, Q9H195, Q9UKN1, Q9H3R2, Q685J3, P98160, Q05793, Q6ZMR5, Q86T26, 
O60235, Q9UL52, Q6ZWK6, Q5DID0, were downloaded using the Uniprot search 
function in Geneious software v5.3.6.  More information on each of the proteins can 
be found in table five. 
  The SEA module sequence from each of the proteins listed above were 
extracted from the parent protein sequence and used in sequence alignments.  
Information on each of the SEA module sequences can be found in table six.  The 
first alignment compared the sequences of human SEA modules from agrin, ENTK, 
GP110, GP116, IMPG1, IMPG2, MUC1, MUC3A, MUC3B, PLN, TM11A, TM11B, 
TM11D, TM11E, TM11F, and UROL1 using a Geneious alignment. The alignment was 
a global alignment without free end gaps.  It used a Blosum62 (BLOcks of Amino 
Acid SUbstitution Matrix)  cost matrix, an open gap penalty of 12, a gap extension 
penalty of three, and an exception of one.  The alignment was run through ten  
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PLN_SEA_GWVFV Modeling Templates 
     
# Template  Confidence 
% 
i.d.  
Template Information 
1 c3ewgA_ 28.3 35 
PDB header:transcription 
Chain: A: PDB Molecule:putative transcription 
antitermination protein nusg; 
PDBTitle: crystal structure of the n-terminal domain of 
nusg (ngn) from2 methanocaldococcus jannaschii 
2 c3h7hB_ 21.4 35 
PDB header:transcription 
Chain: B: PDB Molecule:transcription elongation factor 
spt5; 
PDBTitle: crystal structure of the human transcription 
elongation factor dsif,2 hspt4/hspt5 (176-273) 
3 c2exuA_ 19.4 17 
PDB header:transcription 
Chain: A: PDB Molecule:transcription initiation 
protein spt4/spt5; 
PDBTitle: crystal structure of saccharomyces 
cerevisiae transcription elongation2 factors spt4-
spt5ngn domain 
4 c3p8bB_ 18.9 20 
PDB header:transferase/transcription 
Chain: B: PDB Molecule:transcription antitermination 
protein nusg; 
PDBTitle: x-ray crystal structure of pyrococcus 
furiosus transcription2 elongation factor spt4/5 
5 d1hh2p1 14.6 17 
Fold:OB-fold 
Superfamily:Nucleic acid-binding proteins 
Family:Cold shock DNA-binding domain-like 
6 c2k9kA_ 10.9 17 
PDB header:metal transport 
Chain: A: PDB Molecule:tonb2; 
PDBTitle: molecular characterization of the tonb2 
protein from vibrio2 anguillarum 
7 d2gskb1 10.3 38 
Fold:TolA/TonB C-terminal domain 
Superfamily:TolA/TonB C-terminal domain 
Family:TonB 
8 d1ihra_ 9.6 38 
Fold:TolA/TonB C-terminal domain 
Superfamily:TolA/TonB C-terminal domain 
Family:TonB 
9 c3d89A_ 9.4 24 
PDB header:electron transport 
Chain: A: PDB Molecule:rieske domain-containing 
protein; 
PDBTitle: crystal structure of a soluble rieske 
ferredoxin from mus musculus 
10 c2x3wD_ 8.4 24 
PDB header:endocytosis 
Chain: D: PDB Molecule:protein kinase c and casein 
kinase substrate in neurons 
PDBTitle: structure of mouse syndapin i (crystal form 
2) 
 
 
 
 
 
 
 
 
 
 
 35 
11 d2cp5a1 7.1 38 Fold:SH3-like barrel 
Superfamily:Cap-Gly domain 
Family:Cap-Gly domain 
12 d1ulia1 6.6 19 
Fold:ISP domain 
Superfamily:ISP domain 
Family:Ring hydroxylating alpha subunit ISP domain 
13 c2i7fB_ 6.5 33 
PDB header:oxidoreductase 
Chain: B: PDB Molecule:ferredoxin component of 
dioxygenase; 
PDBTitle: sphingomonas yanoikuyae b1 ferredoxin 
14 d2e3ha1 6 53 
Fold:SH3-like barrel 
Superfamily:Cap-Gly domain 
Family:Cap-Gly domain 
15 d1ks0a_ 5.8 63 
Fold:Kringle-like 
Superfamily:Kringle-like 
Family:Fibronectin type II module 
16 d1ixda_ 5.7 27 
Fold:SH3-like barrel 
Superfamily:Cap-Gly domain 
Family:Cap-Gly domain 
17 d2gxfa1 5.6 43 
Fold:Cystatin-like 
Superfamily:NTF2-like 
Family:YybH-like 
18 c3dqyA_ 5.4 44 
PDB header:oxidoreductase 
Chain: A: PDB Molecule:toluene 1,2-dioxygenase 
system ferredoxin 
PDBTitle: crystal structure of toluene 2,3-dioxygenase 
ferredoxin 
19 d1knwa1 5.3 24 
Fold:Domain of alpha and beta subunits of F1 ATP 
synthase-like 
Superfamily:Alanine racemase C-terminal domain-like 
Family:Eukaryotic ODC-like 
 
 
 
 
 
 
 
 
Table 2 – Phyre2 results for PLN SEA autocleavage peptide modeling. 
Phyre2 returned a list of proteins that could be used as a template for modeling the 
PLN SEA autocleavage peptide.  Each protein is listed by its PDB id, given a 
confidence score, the percent of matching protein sequence is listed, and some 
descriptive information. 
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Muc1_SEA_GSVVV Modeling Templates 
    
 
# Template  Confidence 
% 
i.d.  
Template Information 
1 c2acmB 97.2 100 
PDB header:structural protein 
Chain: B: PDB Molecule:mucin-1; 
PDBTitle: solution structure of the sea domain of 
human mucin 1 (muc1) 
2 c2acmA 95.8 100 
PDB header:structural protein 
Chain: A: PDB Molecule:mucin-1; 
PDBTitle: solution structure of the sea domain of 
human mucin 1 (muc1) 
3 c2e7vA 88.4 29 
PDB header:hydrolase 
Chain: A: PDB Molecule:transmembrane protease; 
PDBTitle: crystal structure of sea domain of 
transmembrane protease2 from mus musculus 
4 c1cf1B 50.4 67 
PDB header:structural protein 
Chain: B: PDB Molecule:protein (arrestin); 
PDBTitle: arrestin from bovine rod outer segments 
5 c1ayrA 40.5 67 
PDB header:sensory transduction 
Chain: A: PDB Molecule:arrestin; 
PDBTitle: arrestin from bovine rod outer segments 
6 d1g4ma1 30.5 67 
Fold:Immunoglobulin-like beta-sandwich 
Superfamily:E set domains 
Family:Arrestin/Vps26-like 
7 d1cf1a1 30.4 67 
Fold:Immunoglobulin-like beta-sandwich 
Superfamily:E set domains 
Family:Arrestin/Vps26-like 
8 c1jsyA_ 27.4 67 
PDB header:signaling protein 
Chain: A: PDB Molecule:bovine arrestin-2 (full 
length); 
PDBTitle: crystal structure of bovine arrestin-2 
9 c2uvaI_ 12.3 62 
PDB header:transferase 
Chain: I: PDB Molecule:fatty acid synthase beta 
subunits; 
PDBTitle: crystal structure of fatty acid synthase 
from thermomyces2 lanuginosus at 3.1 angstrom 
resolution. this file contains3 the beta subunits of 
the fatty acid synthase. the entire4 crystal 
structure consists of one heterododecameric fatty5 
acid synthase and is described in remark 400 
10 c2vkzH_ 11.3 46 
PDB header:transferase 
Chain: H: PDB Molecule:fatty acid synthase subunit 
beta; 
PDBTitle: structure of the cerulenin-inhibited 
fungal fatty acid2 synthase type i multienzyme 
complex 
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11 c1sujA_ 9.5 67 PDB header:signaling protein 
Chain: A: PDB Molecule:cone arrestin; 
PDBTitle: x-ray crystal structure of ambystoma 
tigrinum cone arrestin 
12 d1d2oa1 7.6 50 
Fold:Prealbumin-like 
Superfamily:Cna protein B-type domain 
Family:Cna protein B-type domain 
13 d1s1da_ 7.2 45 
Fold:5-bladed beta-propeller 
Superfamily:Apyrase 
Family:Apyrase 
14 d1d2oa2 7.1 40 
Fold:Prealbumin-like 
Superfamily:Cna protein B-type domain 
Family:Cna protein B-type domain 
15 d1ik9a1 5.8 36 
Fold:XRCC4, N-terminal domain 
Superfamily:XRCC4, N-terminal domain 
Family:XRCC4, N-terminal domain 
16 c1g4mA_ 5.2 67 
PDB header:signaling protein 
Chain: A: PDB Molecule:beta-arrestin1; 
PDBTitle: crystal structure of bovine beta-arrestin 
1  
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 - Phyre2 results for MUC1 SEA autocleavage peptide modeling. 
Phyre2 returned a list of proteins that could be used as a template for modeling the 
PLN SEA autocleavage peptide.  Each protein is listed by its PDB id, given a 
confidence score, the percent of matching protein sequence is listed, and some 
descriptive information. 
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Figure 11 – Model of autocleavage regions of PLN and MUC1 SEAs. 
Models created by Phyre2.  Structures are displayed in the NewCartoon style using 
VMD visualization software.  Autocleavage motif residues are highlighted as 
semitransparent space filling residues.  A) PLN SEA autocleavage peptide.  Residues 
62-67 (GWVFV) of the PLN SEA are highlighted, corresponding to residues 142 – 
146 of PLN. B) MUC1 SEA autocleavage peptide.  Residues 64 – 68 (GSVVV) are 
highlighted.  These correspond to residues 1097 – 1011 of MUC1. 
A   PLN SEA 
B   MUC1 SEA 
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refinement iterations.  The information from this alignment combined with 
information from other SEA modules studies led to a second alignment with SEAs 
from fewer proteins but more species.  The SEA modules from ENTK, GP110, GP116, 
MUC1, MUC3A, MUC3B, MUC12, MUC17, PLN, UROL1, and the second SEA module of 
IMPG1 and IMPG2 of different species were analyzed using the same Geneious 
alignment with Blosum62 score matrix.  A third alignment using the same methods 
above was performed on DAG1, GP116, MUC1, Muc3A, MUC3B, MUC12, and 
TMPRSS6 for autocleavage predictions. 
2.6.2. Folding predictions 
The PLN SEA module sequence from table six was used for the folding 
predictions.  No changes or mutations were added to the sequence.  The sequence 
was put into the web based protein folding prediction website Phyre2 (Kelley and 
Sternberg, 2009).  The job was given a unique identifier (1a9df393dfac51a5) and 
the results were emailed to me.  Multiple proteins were returned as possible 
templates for folding but the one with the highest confidence was used to create the 
folding model regardless of the percent identity match.  The downloaded model was 
viewed and manipulated using VMD software v1.9.1 (Humphrey et al., 1996).  The 
PLN SEA model and the MUC1 SEA (PDB ID - 2ACM) were both displayed in this 
software.  The molecules were drawn in the New Cartoon style and colored based 
on the secondary structure.  Residues in the autocleavage motif were located in the 
 40 
Sequence viewer window under the Extensions tab in the Analysis subfolder.  The 
autocleavage residues were visually highlighted as beads. 
The same methods were used to evaluate the fold of the short 31 amino acid 
sequences of the autocleavage region and the models need for autocleavage 
predictions.  The sequences were separately pasted into the Phyre2 program.  The 
resulting models were rendered in VMD.  Each model was drawn in the New 
Cartoon style and colored based on the secondary structure.  The autocleavage 
motif was highlighted through the same procedure, but visually emphasized with a 
semitransparent surface representation around the residues.  This was done to 
identify the region of potential cleavage while still allowing the fold around the 
residues to be seen.  The prediction models highlight the phenylalanine, glycine, and 
serine mentioned in section 2.4.  This was done to show the proximity of the 
phenylalanine to the autocleavage region. 
2.6.3. Recombinant protein production and isolation 
Initially the DNA encoding the PLN and MUC1 SEA modules needed to be 
isolated and amplified in order to begin the molecular cloning necessary for protein 
expression.  The transcript sequence for PLN (PLN - ENST00000374695) and thus 
the PLN SEA was obtained from Ensembl (http://useast.ensembl.org/index.html).  
Using the transcript information custom forward and reverse primers were  
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Figure 12 – Sequence alignment of autocleaving SEA modules. 
Geneious alignment with a Blosum62 cost matrix and an exception of 1.  Highlighted 
residues have 100% consensus across the sequence alignment.  SEAs in this 
alignment include DAG1, GP116, MUC1, MUC3A, MUC3B, MUC12, and TMPRSS6 
from various species. 
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Figure 13 – Modeling location of fully conserved residues in autocleaving SEA 
modules. 
Models created by Phyre2.  Structures are displayed in the NewCartoon style using 
VMD visualization software.  Residues noted from figure 12 are highlighted as 
surface representations.  The glycine is colored white.  The serine is yellow and the 
phenylalanine is purple.  MUC1 and GP116 SEA modules are known to autocleave.  
IMPG2 (2 of 2) is predicted to autocleave.  
MUC1 GP116 
IMPG2 (2 of 2) 
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Autocleaves 
Does not 
autocleave 
Predicted to 
autocleave 
Predicted not to 
autocleave 
DAG1_Bovine PLN_Human GP110_Human AGRIN_Chicken 
DAG1_Dog PLN_Mouse GP110_Mouse AGRIN_Electric ray 
DAG1_Human   IMPG1_Bovine(2 of 2) AGRIN_Human 
DAG1_Mouse   IMPG1_Human(2 of 2) AGRIN_Mouse 
DAG1_Rabbit   IMPG1_Mouse(2 of 2) AGRIN_Rat 
GP116_Human   IMPG1_Rat(2 of 2) DESC4_Mouse 
GP116_Rat   IMPG2_Chicken(2 of 2) DESC4_Rat 
MUC01_Bovine   IMPG2_Human(2 of 2) ENTK_Bovine 
MUC01_Gibbon   IMPG2_Mouse(2 of 2) ENTK_Human 
MUC01_Hamster   IMPG2_Rat(2 of 2) ENTK_Mouse 
MUC01_Human   MUC17_Human ENTK_Pig 
MUC01_Mouse   TMPRSS6_Rat IMPG1_Bovine(1 of 2) 
MUC03A_Human     IMPG1_Chicken 
MUC03B_Human     IMPG1_Human(1 of 2) 
MUC12_Human     IMPG1_Mouse(1 of 2) 
      IMPG1_Rat(1 of 2) 
      IMPG2_Chicken(1 of 2) 
      IMPG2_Human(1 of 2) 
      IMPG2_Mouse(1 of 2) 
      IMPG2_Rat(1 of 2) 
      MUA3_Caeel 
      MUC13_Human 
      MUC13_Mouse 
      MUC13_Rat 
      SP63_Sea urchin 
      TM11A_Human 
      TM11A_Mouse 
      TM11B_Human 
      TM11B_Mouse 
      TM11B_Rat 
      TM11D_Human 
      TM11D_Mouse 
      TM11D_Rat 
      TM11E_Human 
      TM11E_Mouse 
      TM11F_Human 
      TM11F_Mouse 
      UROL1_Human(1of2) 
      UROL1_Human(2of2) 
Table 4 – Autocleavage predictions. 
The SEAs list as ones the autocleave were identified from literature.  PLN SEA 
modules does not autocleave based on this work.  The SEAs predicted to autocleave 
have both the phenylalanine and the glycine/serine of the autocleavage motif 
identified in figure12 and highlighted in figure 13.  The SEAs predicted not to 
autocleave lack one or both of the features.   
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designed and ordered from Integrated DNA Technologies to amplify each of the SEA 
sequences.  
Two sets of primers were designed for each SEA module.  The set used to 
create an N-terminally tagged expression construct removed the start codon from 
the initial SEA sequence to later add it before the HIS tag by the recombination 
event with the destination vector.  This set of primers also maintained the stop 
codon from the original sequence.  The set of primers used to create the C-
terminally tagged expression construct removed the stop codon from the sequence 
so that it could be added back after the HIS tag by the destination vector.  This set of 
primers also maintained the start codon from the original sequence.   
 
cDNA from a pancreatic epithelial cell line (HPAF), kindly provided by 
another graduate student in the laboratory, Patricia Chapela, was used as the 
template for the initial PCR reaction.  The PCR reaction was combined and cycled 
using a typical PCR protocol.  The products were separated on an 1.5% (w/v) 
agarose gel containing 1µl of 10 mg/mL ethidium bromide.  Bands that 
corresponded to the correct sized were cut from the gel and the DNA was extracted 
with a Qiagen gel extraction kit.  All DNA was sequenced by LoneStar labs (Houston, 
TX) before moving forward with the cloning process. 
The sequence verified DNA was combined with either the pENTR/SD/D-
TOPO or the pENTR/D-TOPO (Life Technologies) depending on whether the goal 
was to create an N- or C- terminally tagged final product.  The reaction was 
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maintained at 30 minutes at room temperature before being placed on ice.  The 
reaction products were transformed into chemically competent One Shot® TOP10 
E. coli and plated on kanamycin containing LB agar plates.  Positive colonies were 
selected and grown over night in selective LB broth.  The plasmids were isolated 
using the Qiagen miniprep kit and sequenced by Lonestar labs (Houston, TX).  
Sequenced verified entry clones and destination clones were combined with the LR 
Clonase™ II enzyme mix in TE buffer to perform the recombination reaction.  The 
reaction was held at room temperature for one hour before proteinase K was added 
and the reaction was moved to 37°C for ten minutes.  A small volume was 
transformed into competent cells as before and plated on ampicillin containing LB 
agar plates.  Positive colonies were grown in broth overnight and their plasmid 
isolated and sequenced as described above.  All sequence analysis data from 
Lonestar Labs (Houston, TX) was analyzed using Geneious software v5.3.6.  More 
information on the vectors used for cloning can be found in figure 15. 
To produce protein, destination vectors were transformed into chemically 
competent E. coli designed for the expression of recombinant protein, One Shot® 
BL21 Star™ (DE3) Chemically Competent E. coli (Life Technologies).  Transformed 
cells were inoculated into 5ml 2YT media containing ampicillin and grown 
overnight in a 37⁰C incubator.  The overnight broth was inoculated into 1 liter of 
selective 2xYT media and grown in a 37⁰C shaker until OD600 = 1.0.  1mM isopropyl  
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Figure 14 – Space filling SEA model of conserved residues. 
A) Blue coloring highlights conserved residues among various SEA modules.  Dark 
blue denotes surface exposed residues.  Light blue denotes conserver residues 
buried  in the fold.  B)  Yellow denoted conserved hydrophobic solvent facing 
residues.  Specific residues are noted by an (star) on figure 6.  Images made in 
collaboration with Drew Bryant (see text). 
Autocleavage 
site 
A 
B 
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β-D-1-thiogalactopyranoside (IPTG) (0.238g) was added to the culture to induce 
protein production.  The culture was left in the incubator overnight.  To collect the 
protein produced the culture was first spun down at 10,000 rpm for 30 minutes and 
the supernatant removed. The cell pellet was lysed through a series of freeze thaw 
cycles in liquid nitrogen. After each cycle 10ml of buffer supplemented with 5mM 
phenylmethylsulfonyl fluoride, 5mM Nα-p-Tosyl-L-arginine methyl ester 
hydrochloride, and 100μg/ml lysozyme.  After the third freeze/thaw 10ml of buffer 
containing 0.01g of DNase was added and the solution was allowed to sit on ice until 
it was fluid.  The lysate was then centrifuged at 12,000 rpm for 30 minutes and the 
supernatant or cell lysate was collected.  The whole cell lysate was stored at 4°C. 
Recombinant protein was isolated from the whole cell lysate using metal ion 
chromatography. The HIS tagged SEA modules were bound to the Ni-NTA column by 
gently tumbling the lysate in the column for one hour at 4°C.  The rest of the lysate 
was applied to the column.   The column was then washed with a series of low 
concentration imidazole buffers (50mM NaH2PO4, 300mM NaCl, 10-20mM 
imidazole, pH – 8).  The protein of interest was eluted with a high concentration 
(300mM) imidazole buffer.  Protein samples were stored 4°C with 0.02% (w/v) 
sodium azide.  Precipitated protein was subjected to ten 30 second rounds of bore 
sonication while on ice in order to resolubilize the material in the extract. 
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Purified recombinant protein stability in different pHs was tested prior to 
further analysis.  Proteins were dialyzed in a 1kDa molecular weight cut off Tube-O-
DIALYZER (G Biosciences) into elution buffer of pHs ranging from five to eight.  The 
protein was dialyzed overnight in 4°C.  Samples from each pH were electrophoresed 
on a gradient NuPAGE® 4-12% Bis Tris gel (Life Technologies).  The gel was 
Coomassie stained overnight and destained overnight at room temperature.  
Alterations in the proteins due to the pH if any were compared sample to sample. 
2.6.4. Autocleavage analysis 
Autocleavage was analyzed via two different methods, first by coomassie 
stain SDS-PAGE gels and second by western blot.  For the Coomassie analysis two 
different samples had to be taken from each protein expression procedure.  The first 
sample was removed from the 1 liter culture just before IPTG was added and 
protein production begins.  The second sample was removed after protein 
production just before the cells were pelleted.  The two small samples were 
centrifuged and the supernatant discarded.  The pellet was resuspended in 100µl of 
8M urea buffer.  The sample was recentrifuged and the cell debris was discarded, 
saving only the supernatant.  These samples were electrophoresed on a gradient 
SDS-PAGE gel to separate the proteins found in the whole cell lysate.  The gel was 
Coomassie stained overnight at room temperature and then de-stained overnight at 
room temperature.  Gels were imaged on a Kodak Image Station 4000MM PRO from  
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ID Species 
Accession 
Number 
Length 
(AA) 
Name or Description 
AGRIN_HUMAN Homo sapiens O00468 2045 Agrin 
ENTK_BOVIN Bos taurus P98072 1035 
Enteropeptidase 
Enterokinase 
Serine protease 7 
Transmembrane protease serine 15 
ENTK_HUMAN Homo sapiens P98073 1019 
Enteropeptidase 
Enterokinase 
Serine protease 7 
Transmembrane protease serine 15 
ENTK_MOUSE Mus musculus P97435 1069 
Enterokinase 
Enteropeptidase 
Serine protease 7 
Transmembrane protease serine 15 
ENTK_PIG Sus scrofa P98074 1034 
Enteropeptidase 
Enterokinase 
Serine protease 7 
Transmembrane protease serine 15 
GP110_HUMAN Homo sapiens Q5T601 910 
Probable G-protein coupled receptor 110 
G-protein coupled receptor KPG_012 
G-protein coupled receptor PGR19 
GP110_MOUSE Mus musculus Q8VEC3 908 G-protein coupled receptor 110 
GP116_HUMAN Homo sapiens Q8IZF2 1346 Probable G-protein coupled receptor 116 
GP116_RAT Rattus norvegicus Q9WVT0 1349 
Probable G-protein coupled receptor 116 
G-protein coupled hepta-helical receptor 
Ig-hepta 
IMPG1_BOVIN Bos taurus Q9GMS5 794 
Interphotoreceptor matrix proteoglycan 1 
Mucin-like glycoprotein associated with 
photoreceptor cells 
Sialoprotein associated with cones and 
rods 
IMPG1_HUMAN Homo sapiens Q17R60 797 
Interphotoreceptor matrix proteoglycan 1 
Interphotoreceptor matrix proteoglycan 
of 150 kDa 
Sialoprotein associated with cones and 
rods 
IMPG1_MOUSE Mus musculus Q8R1W8 798 
Interphotoreceptor matrix proteoglycan 1 
Interphotoreceptor matrix proteoglycan 
of 150 kDa 
Sialoprotein associated with cones and 
rods 
IMPG1_RAT Rattus norvegicus Q9ET62 798 
Interphotoreceptor matrix proteoglycan 1 
Mucin-like glycoprotein associated with 
photoreceptor cells 
Sialoprotein associated with cones and 
rods 
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IMPG2_CHICK 
 
Gallus gallus 
 
Q1XI86 
 
1423 
Interphotoreceptor matrix proteoglycan 2 
Sialoprotein associated with cones and 
rods proteoglycan 
Sparcan 
IMPG2_HUMAN Homo sapiens Q9BZV3 1241 
Interphotoreceptor matrix proteoglycan 2 
Interphotoreceptor matrix proteoglycan 
of 200 kDa 
Sialoprotein associated with cones and 
rods proteoglycan or Sparcan 
IMPG2_MOUSE Mus musculus Q80XH2 1243 
Interphotoreceptor matrix proteoglycan 2 
Sparcan 
IMPG2_RAT Rattus norvegicus P70628 1241 
Interphotoreceptor matrix proteoglycan 2 
Sparcan 
MUC1_BOVIN Bos taurus Q8WML4 580 
Mucin-1 
CD_antigen=CD227 
MUC1_HUMAN Homo sapiens P15941 1255 
Mucin-1 
Breast carcinoma-associated antigen DF3 
Episialin 
H23AG 
Krebs von den Lungen-6 
PEMT 
Peanut-reactive urinary mucin 
Polymorphic epithelial mucin 
Tumor-associated epithelial membrane 
antigen 
CD_antigen=CD227 
MUC1_HYLLA 
Hylobates lar 
(gibbon) 
Q29435 475 
Mucin-1 
CD_antigen=CD227 
MUC1_MESAU 
Mesocricetus auratus 
(golden hamster) 
Q60528 676 
Mucin-1 
CD_antigen=CD227 
MUC1_MOUSE Mus musculus Q02496 630 
Mucin-1 
Episialin 
CD_antigen=CD227 
MUC3A_HUMAN Homo sapiens Q02505 2541 
Mucin-3A 
Intestinal mucin-3A 
MUC3B_HUMAN Homo sapiens Q9H195 901 
Mucin-3B 
Intestinal mucin-3B 
MUC12_HUMAN Homo sapiens Q9UKN1 5478 Mucin-12 
MUC13_HUMAN Homo sapiens Q9H3R2 511 
Mucin-13 
Down-regulated in colon cancer 1 
MUC17_HUMAN Homo sapiens Q685J3 4493 
Mucin-17 
Small intestinal mucin-3 
PGBM_HUMAN Homo sapiens P98160 4391 
Basement membrane-specific heparan 
sulfate proteoglycan core protein 
Perlecan 
PGBM_MOUSE Mus musculus Q05793 3707 
Basement membrane-specific heparan 
sulfate proteoglycan core protein 
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TM11A_HUMAN 
 
 
Homo sapiens 
 
 
Q6ZMR5 
 
 
421 
Transmembrane protease serine 11A 
Airway trypsin-like protease 1 
Epidermal type-II transmembrane serine 
protease 
Esophageal cancer-susceptibility gene 1 
protein 
TM11B_HUMAN Homo sapiens Q86T26 416 
Transmembrane protease serine 11B 
Airway trypsin-like protease 5 
TM11D_HUMAN Homo sapiens O60235 418 
Transmembrane protease serine 11D 
Airway trypsin-like protease 
Transmembrane protease serine 11D non-
catalytic chain 
TM11E_HUMAN Homo sapiens Q9UL52 423 
Transmembrane protease serine 11E 
Serine protease DESC1 
Transmembrane protease serine 11E2 
TM11F_HUMAN Homo sapiens Q6ZWK6 438 
Transmembrane protease serine 11F 
Airway trypsin-like protease 4 
UROL1_HUMAN Homo sapiens Q5DID0 1381 
Uromodulin-like 1 
Olfactorin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 - Protein list.  
A list of the proteins containing an SEA module used in sequence alignments is listed 
with the species specific to it, the accession number, its length, and alternative 
names.  Information on human PLN is highlighted. 
 52 
SEA Module ID Length Position 
Sequence   
 
AGRIN_HUMAN  123 1130-1252 
ATKVFQGVLELEGVEGQELFYTPEMADPKSELFGETARSIESTLDDLFRNSDVKKDFRSVRLRDLGPGKSV
RAIVDVHFDPTTAFRAPDVARALLRQIQVSRRRSLGVRRPLQEHVRFMDFDW   
 
ENTK_BOVIN  116 54-169 
KSHEARGTLKIISGATYNPHLQDKLSVDFKVLAFDIQQMIDDIFQSSNLKNEYKNSRVLQFENGSIIVIFD
LLFDQWVSDKNVKEELIQGIEANKSSQLVTFHIDLNSIDITASLE   
 
ENTK_HUMAN  118 52-169 
LGQSHEARATFKITSGVTYNPNLQDKLSVDFKVLAFDLQQMIDEIFLSSNLKNEYKNSRVLQFENGSIIVV
FDLFFAQWVSDENVKEELIQGLEANKSSQLVTFHIDLNSVDILDKLT   
 
ENTK_MOUSE  118 52-169 
LGKSHEVRGTFKITSGVTYNPNLQDKHSVDFKVLAFDLQQMIDEIFESSSLKNEYEKSKVFQFEKGSVIVL
FDLFFAQWVSDKNVKEELIQGIEANISSQLVTLHIDLNSIDITASLS   
 
ENTK_PIG  118 52-169 
LGKSHEARGTMKITSGVTYNPNLQDKLSVDFKVLAFDIQQMIGEIFQSSNLKNEYKNSRVLQFENGSVIVI
FDLLFAQWVSDENIKEELIQGIEANKSSQLVAFHIDVNSIDITESLE   
 
GP110_HUMAN  107 146-252 
FCERTKIWGTFKINERFTNDLLNSSSAIYSKYANGIEIQLKKAYERIQGFESVQVTQFRNGSIVAGYEVVG
SSSASELLSAIEHVAEKAKTALHKLFPLEDGSFRVF   
 
GP110_MOUSE  107 145-251 
FCERAKVWGTFEIDEKFPEDLWNSSSDVYAHYTVGIENQLKEAYRRVHGFESVRVTQFRKGSIVVGYEVTG
STSPPELLFAIEQEAEKAQEALRRQFPVKYGSFRVF   
 
GP116_HUMAN  119 163-281 
FCLLQEDVTLNMRVRLNVGFQEDLMNTSSALYRSYKTDLETAFRKGYGILPGFKGVTVTGFKSGSVVVTYE
VKTTPPSLELIHKANEQVVQSLNQTYKMDYNSFQAVTINESNFFVTPE   
 
GP116_RAT  121 159-279 
FCQLPETYITLKIKVRLNIGFQEDLENTSSALYRSYKTDLERAFRAGYRTLPGFRSVTVTQFTKGSVVVDY
IVEVASAPLPGSIHKANEQVIQNLNQTYKMDYNSFQGTPSNETKFTVTPE   
 
IMPG1-2_BOVIN  119 575-693 
AARGRELVVFFSLRVANVPFSTDLFNKSSLEYQALEQRFTQLLVPNLRSNLTGFKQLEILNFRNGSVIVNS
KVRFAKSVPYNLTKAVRGVLEDFRSTAAQQLDLEIDSYSLDVEPADQA   
 
IMPG1-1_HUMAN 116 230-345 
VLEEQRVELSVSLVNQKFKAELADSQSPYYQELAGKSQLQMQKIFKKLPGFKKIHVLGFRPKKEKDGSSST
EMQLTAIFKRHSAEAKSPASDLLSFDSNKIESEEVYHGTMEEDKQ   
 
IMPG1-2_HUMAN 119 567-685 
APKGRELVVFFSLRVANMAFSNDLFNKSSLEYRALEQQFTQLLVPYLRSNLTGFKQLEILNFRNGSVIVNS
KMKFAKSVPYNLTKAVHGVLEDFRSAAAQQLHLEIDSYSLNIEPADQA   
 
IMPG1-2_MOUSE 119 571-689 
ATKGQELVVFFSLRVANMPFSYDLFNKSSLEYQALEQRFTDLLVPYLRSNLTGFKQLEILSFRNGSVIVNS
KVRFAKAVPYNLTQAVRGVLEDLRSTAAQGLNLEIESYSLDIEPADQA   
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IMPG1-2_RAT  119 570-688 
AAKGHELVVFFSLRVANMPFSYDLFNKSSLEYQALEQRFTDLLVPYLRSNLTGFKQLEILSFRNGSVIVNS
KVRFAKAVPYNLTQAVRGVLEDLRSTAAQELNLEIESYSLDIEPADQA   
 
IMPG2-2_CHICK  119 1079-1197 
PVPSRALVVFFSLRVTNMMFSEDLFNKNSPEYKALEQRFLELLVPYLQSNLTGFQNLEILNFRNGSIVVNS
RMKFAKPVPRNVTNAVYMILEDFCNTAYHTMNLAIDKYSLDVESGEQA   
 
IMPG2-1_HUMAN 123 234-356 
ATKPAGEQIAEFSIHLLGKQYREELQDSSSFHHQHLEEEFISEVENAFTGLPGYKEIRVLEFRSPKENDSG
VDVYYAVTFNGEAISNTTWDLISLHSNKVENHGLVELDDKPTVVYTISNFRD   
 
IMPG2-2_HUMAN 120 892-1011 
YTQTSGALVVFFSLRVTNMMFSEDLFNKNSLEYKALEQRFLELLVPYLQSNLTGFQNLEILNFRNGSIVVN
SRMKFANSVPPNVNNAVYMILEDFCTTAYNTMNLAIDKYSLDVESGDEA   
 
IMPG2-2_MOUSE 122 895-1016 
HTQTAGALVVFFSLRVTNMLFSEDLFNKNSLEYKALEQRFLELLVPYLQSNLSGFQNLEILSFRNGSIVVN
SRVRFAESAPPNVNKAMYRILEDFCTTAYQTMNLDIDKYSLDVESGDEANP   
 
IMPG2-2_RAT  124 895-1018 
RTQTAGALVVFFSLRVTNMLFSEDLFNKNSLEYKALEQRFLELLVPYLQSNLSGFQNLEILNFRNGSIVVN
SRVKFAESVPPNVNNAIYMILEDFCTTAYQTMNLDIDKYSLDVESGDDANPCK   
 
MUC1_BOVIN  116 363-478 
QQLSVRVSLYFLSFRITNLQFNSSLENPQTSYYQELQRSIWGLILQIYKQRDFLGLSEIKFRPGSVVVELT
LAFREGTTAEWVKAQFSQLEAHAASYNLTISGVSVYSAPFPSSAQ   
 
MUC1_HUMAN  119 1034-1152 
PQLSTGVSFFFLSFHISNLQFNSSLEDPSTDYYQELQRDISEMFLQIYKQGGFLGLSNIKFRPGSVVVQLT
LAFREGTINVHDVETQFNQYKTEAASRYNLTISDVSVSDVPFPFSAQS   
 
MUC1_HYLLA  119 254-372 
PQLSIGVSFFFLSFHISNLQFNSSLEDPSTNYYQELQRDISELILQIYKQGDFLGVSNIKFRPGSVVVQST
LAFREGTTNVHDVEAQFNQHKTEAASRYNLTISDVSVSDVPFPFSAQS   
 
MUC1_MESAU  117 458-574 
PQVSVGVSFFLLSFHIWNHQFNSSLEDPSSNYYQELKRNVSGLFLQVFSRAFLGISTIEFRSGSVVVDSTV
IFREGAVNASEVKSQLLQHEQEAEEYNLAISKINVGEMQFPSSAQS   
 
MUC1_MOUSE  116 411-526 
PQLSVGVSFFFLSFYIQNHPFNSSLEDPSSNYYQELKRNISGLFLQIFNGDFLGISSIKFRSGSVVVESTV
VFREGTFSASDVKSQLIQHKKEADDYNLTISEVKVNEMQFPPSAQ   
 
MUC12_HUMAN  128 5163-5290 
ETPEKLNATLGMTVKVTYRNFTEKMNDASSQEYQNFSTLFKNRMDVVLKGDNLPQYRGVNIRRLLNGSIVV
KNDVILEADYTLEYEELFENLAEIVKAKIMNETRTTLLDPDSCRKAILCYSEEDTFV   
 
MUC13_HUMAN  110 211-320 
KGKVFPGKISVTVSETFDPEEKHSMAYQDLHSEITSLFKDVFGTSVYGQTVILTVSTSLSPRSEMRADDKF
VNVTIVTILAETTSDNEKTVTEKINKAIRSSSSNFLNYD   
 
MUC17_HUMAN  115 4182-4296 
ETISAQMELTVTVTSVKFTEELKNHSSQEFQEFKQTFTEQMNIVYSGIPEYVGVNITKLRLGSVVVEHDVL
LRTKYTPEYKTVLDNATEVVKEKITKVTTQQIMINDICSDMMCF   
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MUC3A_HUMAN  121 2236-2356 
DVVETEVGMEVSVDQQFSPDLNDNTSQAYRDFNKTFWNQMQKIFADMQGFTFKGVEILSLRNGSIVVDYLV
LLEMPFSPQLESEYEQVKTTLKEGLQNASQDANSCQDSQTLCFKPDSIKV   
 
MUC3B_HUMAN  121 596-716 
DVVETEVGMEVSVDQQFSPDLNDNTSQAYRDFNKTFWNQMQKIFADMQGFTFKGVEILSLRNGSIVVDYLV
LLEMPFSPQLESEYEQVKTTLKEGLQNASQDANSCQDSQALCFKPDSIKV   
 
PLN_HUMAN  115 80-194 
QMVYFRALVNFTRSIEYSPQLEDAGSREFREVSEAVVDTLESEYLKIPGDQVVSVVFIKELDGWVFVELDV
GSEGNADGAQIQEMLLRVISSGSVASYVTSPQGFQFRRLGTVPQ   
 
PLN_MOUSE  115 80-194 
QMVYFRALVNFTRSIEYSPQLEDASAKEFREVSEAVVEKLEPEYRKIPGDQIVSVVFIKELDGWVFVELDV
GSEGNADGSQIQEVLHTVVSSGSIGPYVTSPWGFKFRRLGTVPQ   
 
TM11A_HUMAN  123 45-167 
DQKKEYYHGSFKILDPQINNNFGQSNTYQLKDLRETTENLVSQVDEIFIDSAWKKNYIKNQVVRLTPEEDG
VKVDVIMVFQFPSTEQRAVREKKIQSILNQKIRNLRALPINASSVQVNAMSS   
 
TM11B_HUMAN  123 38-160 
FLAVEKTYYYQGDFHISGVTYNDNCENAASQASTNLSKDIETKMLNAFQNSSIYKEYVKSEVIKLLPNANG
SNVQLQLKFKFPPAEGVSMRTKIKAKLHQMLKNNMASWNAVPASIKLMEISK   
 
TM11D_HUMAN  121 44-164 
DQKSYFYRSSFQLLNVEYNSQLNSPATQEYRTLSGRIESLITKTFKESNLRNQFIRAHVAKLRQDGSGVRA
DVVMKFQFTRNNNGASMKSRIESVLRQMLNNSGNLEINPSTEITSLTDQA   
 
TM11E_HUMAN  122 44-165 
RYNQKKTYNYYSTLSFTTDKLYAEFGREASNNFTEMSQRLESMVKNAFYKSPLREEFVKSQVIKFSQQKHG
VLAHMLLICRFHSTEDPETVDKIVQLVLHEKLQDAVGPPKVDPHSVKIKKI   
 
TM11F_HUMAN  127 52-178 
VVEDDKSFYYLASFKVTNIKYKENYGIRSSREFIERSHQIERMMSRIFRHSSVGGRFIKSHVIKLSPDEQG
VDILIVLIFRYPSTDSAEQIKKKIEKALYQSLKTKQLSLTINKPSFRLTPIDSKKM   
 
UROL1-1_HUMAN 112 395-506 
TNAQVFEVTIKIVNHNLTEKLLNRSSVEYQDFSRQLLHEVESSFPPVVSDLYRSGKLRMQIVSLQAGSVVV
RLKLTVQDPGFPMGISTLAPILQPLLASTVFQIDRQGTRVQ   
 
UROL1-2_HUMAN 104 787-890 
TAARKLIGKVRIKNVRYSESFRNASSQEYRDFLELFFRMVRGSLPATMCQHMDAGGVRME
VVSVTNGSIVVEFHLLIIADVDVQEVSAAFLTAFQTVPLLEVIR  
 
 
 
 
 
 
Table 6 - SEA list. 
A list of the SEA modules used in the sequence alignments.  The length of the module 
is given with its position in the parent protein.  The sequence used in the alignments 
is stated with each SEA module. 
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Carestream HEALTH (Rochester, New York) and large bands found in the post 
induction sample and not the pre induction sample were identified as protein of 
interest.  Their size was compared to the predicted molecular weight of the 
recombinant protein.  If a band electrophoresed faster than expected the SEA would 
be considered to autocleave and if the protein migrated at the expected size, it can 
be concluded that no autocleavage occurred. 
The second method to analyze autocleavage was western blot analysis.  For 
this method only the purified protein from the nickel column was used and not the 
whole cell lysate.  Final proteins are electrophoresed on gels described above and 
transferred to nitrocellulose membrane overnight at 40 volts for five hours.  The 
membrane was blocked in 3% (w/v) BSA in PBS with 1% (v/v) Tween buffer for 
three hours at room temperature and then rinsed with PBS-Tween.  The anti-HIS 
primary mouse antibody recognizes a sequence of four HISs.  The membrane was 
incubated in primary antibody diluted 1:20,000 in blocking buffer for three hours at 
room temperature and rinsed with PBS-Tween.  The membrane was incubated in 
anti-mouse horseradish peroxidase (HRP) secondary antibody diluted 1:50,000 in 
blocking buffer for one hour at room temperature.  Enhanced chemiluminescence 
(ECL) reagent was added to the blot in equal parts and incubated for five minutes.  
Excess ECL reagent was removed from the membrane and the membrane was 
imaged either on the Kodak Image Station 4000MM PRO or on autoradiography 
film. 
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Figure 15 –Vectors. 
Information and cartoons of the vectors used in the expression of recombinant PLN 
and MUC1 SEA modules.  These images are courtesy of Life Technologies. 
http://products.invitrogen.com/ivgn/product/K242020?ICID=search-product 
http://products.invitrogen.com/ivgn/product/K630001?ICID=search-product 
 
Champion™ 
 pET300/NT-DEST and 
pET301/CT-DEST destination 
vectors 
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2.6.5. Identification of binding residues 
The second sequence alignment identified several conserved hydrophobic 
residues.  In collaboration with Drew Bryant, all of the residues were mapped to a 
space filling model the MUC1 SEA structure (PDB ID - 2ACM).  We narrowed the 
selection to the hydrophobic residues that are surface exposed.  All of this modeling 
work was performed with Chimera interactive visualization and analysis software 
(Pettersen et al., 2004). 
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Chapter 3 
Identification of Perlecan SEA module binding 
proteins 
The identification of hydrophobic patches on the SEA modules surface begs 
the question: what binds to those patches and what is the possible effect on the SEA 
module and the parent protein?  To this end a yeast two-hybrid (Y2H) screen was 
performed to identify PLN SEA binding proteins.  Immunocytochemistry (ICC) was 
performed with mammalian cells in an effort to confirm the Y2H results and rule out 
and procedural artifacts. 
3.1. Identification of binding partners 
Hybrigenics (Paris, France) performed the full scale Y2H screen using the 
PLN SEA that I made as the bait and a cDNA library from human bone marrow 
endothelial cells (HBMEC)(Schweitzer et al., 1997; Zilberfarb et al., 1997) using an 
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a/α cell-to-cell mating scheme (Figure 15).  HBMECs were used for this screen 
because PLN in highly expressed in the bone marrow and any proteins that interact 
with the PLN SEA should be present in these cells.  Of 100 million fragment 
interactions tested, 71 positive clones were identified corresponding to eleven 
genes and variants (Table 7).  The four highest confidence proteins are actin 
filament associated protein 1 (AFAP1), exosome component 9 (EXOSC9), gamma-
aminobutyric acid receptor-associated protein (GABARAP), and F-box protein 28 
(FBXO28).  Of these proteins, I hypothesize that GABARAP is the most likely to be a 
bona fide PLN SEA module binding protein because of its association with vesicles 
and ER to Golgi transport. 
3.2.  Verification of binding partners 
To confirm hits from the Y2H screen ICC was performed.  This approach was 
chosen rather than protein complex immunoprecipitation to avoid topological 
artifacts in the results.  WiDr cells from our lab stock were chosen for 
immunohistochemistry because of the large quantities of PLN they produce (Iozzo, 
1984).  WiDr cells are an adherent colorectal adenocarcinoma epithelial cell line.  
WiDr cells were stained with antibodies specific to either PLN or GABARAP or both.  
PLN localization was identified with A76 antibody and shows PLN intracellularly 
located in vesicles appearing as speckles (Figure 17).  This result is as expected, as it 
is known that PLN trafficks through the secretory pathway prior to secretion.   
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Figure 16 - Yeast two hybrid screen scheme.    
This cartoon depicts the general method used by Hybrigenics to run the Y2H screen. 
Yeast of the a mating type were transformed with the PLN SEA bait plasmid.  Yeast 
of the α mating type were transformed with the HBMEC library of prey plasmids.  
The two populations were allowed to mate creating diploid cells containing both of 
the plasmids.  Instances where interactions with the bait and prey occurred colonies 
grew and were evaluated. 
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PLN 
vs Human Bone Marrow Endothelial Cells 
Fri, Jul 30, 2010 - 12:47 PM 
Screen Parameters 
   
Vector - pB27 (N-LexA-bait-C fusion) 
Nature - cDNA 
   
Processed Clones - 71 (pB27) 
Reference Bait Fragment - HSPG2 (80-194)  
 
Analyzed Interactions - 111 million 
Prey Library - Human Bone Marrow Endothelial Cells 
    Global PBS (for Interactions represented in the Screen) # % 
A Very high confidence in the interaction 3 27.3% 
B High confidence in the interaction 1 9.1% 
C Good confidence in the interaction 0 0.0% 
D 
Moderate confidence in the interaction 
5 45.5% 
This category is the most difficult to interpret because it mixes two classes of 
interactions: 
classes of interactions: 
- False-positive interactions 
- Interactions hardly detectable by the Y2H 
technique (low  
 representation of the mRNA in the library, Prey folding, Prey toxicity 
in yeast) 
E 
Interactions involving highly connected prey domains, warning of non- 
2 18.2% 
specific interaction. The threshold for high 
connectivity is 10 for  
 screens with Human, Mouse, Drosophila and Arabidopsis and 6 for all 
other organisms. They can be classified in different categories: 
'- Prey proteins that are known to be highly connected due to their 
biological function 
'- proteins with a Prey interacting domain that 
contains a known   
protein interaction motif or a biochemically promiscuous motif 
F Experimentally proven technical artifacts 0 0.0% 
Non Appliable 
N/A 
The PBS is a score that is automatically computed through algorithms and cannot be 
attributed for the following reasons : 
- All the fragments of the same reference CDS are antisense 
- The 5p sequence is missing 
- All the fragments of the same reference CDS are either All OOF1 or All OOF2 
- All the fragments of the same reference CDS lie in the 5' or 3' UTR 
 
         
Symbols  Means 
* The fragment contains the full length CDS 
↙ Fragment is fully in 5' UTR 
↘ Fragment is fully in 3' UTR 
х Fragment contains at least one In Frame STOP codon 
[NR] Fragment was found to be non relevant (poor quality, high N density) 
IF 
With regard to the theoretical frame of each corresponding CDS (GeneBank), fragments 
are cloned in frame (IF) if they are in the same frame as Gal4AD.  In general,  
OOF1 
polypeptides synthesized from OOF fragments are not considered of biological 
interest, unless found together with another frame. However, some of the proteins 
OOF2 expressed from an OOF fragment can be translated in the correct frame, due to the 
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existence of natural frame-shift events during translation in yeast 
?? 
- the clone sequence is antisense 
- The 5p sequence is missing 
N Antisense 
Start..Stop Position of the 5p and 3p prey fragment ends, relative to the position of the start codon 
 
Clone 
Name 
Type 
Seq 
Gene Name Start Stop Frame Sense % Id 5p/3p PBS 
pB27_A-8 5p 3p  AFAP1 var2 996 1864 IF Sense 97.5 / 98.5 A 
pB27_A-52 5p 3p  AFAP1 var2 996 1864 IF Sense 96.1 / 97.5 A 
pB27_A-5 5p 3p  AFAP1 var2 996 1864 IF Sense 97.1 / 95.5 A 
pB27_A-9 5p 3p  AFAP1 var2 996 1864 IF Sense 98.8 / 97.8 A 
pB27_A-10 5p 3p  AFAP1 var2 996 1864 IF Sense 98.3 / 98.4 A 
pB27_A-70 5p 3p  AFAP1 var2 996 1864 IF Sense 96.2 / 92.6 A 
pB27_A-29 5p 3p  AFAP1 var2 1149 1886 IF Sense 96.9 / 98.9 A 
pB27_A-43 5p 3p  AFAP1 var2 1161 1783 IF Sense 99.7 / 98.7 A 
pB27_A-40 5p 3p  AFAP1 var2 1161 1783 IF Sense 99.5 / 98.4 A 
pB27_A-58 5p 3p  AFAP1 var2 1161 1783 IF Sense 99.7 / 99.5 A 
pB27_A-37 5p 3p  AFAP1 var2 1161 1783 IF Sense 99.7 / 99.5 A 
pB27_A-69 5p 3p  AFAP1 var2 1233 1801 IF Sense 100.0 / 100.0 A 
pB27_A-4 5p 3p  AFAP1 var2 1323 1809 IF Sense 100.0 / 99.8 A 
pB27_A-67 5p 3p  AFAP1 var2 1323 1809 IF Sense 100.0 / 100.0 A 
pB27_A-35 5p 3p  AFAP1 var2 1416 1883 IF Sense 100.0 / 99.4 A 
pB27_A-49 5p 3p  AFAP1 var2 1416 1883 IF Sense 100.0 / 100.0 A 
pB27_A-20 5p 3p  AFAP1 var2 1443 1813 IF Sense 99.7 / 99.7 A 
pB27_A-73 5p 3p  AFAP1 var2 1443 1813 IF Sense 99.7 / 98.9 A 
pB27_A-48 5p 3p  AFAP1 var2 1443 1813 IF Sense 99.7 / 99.7 A 
pB27_A-38 5p 3p  AFAP1 var2 1458 1859 IF Sense 99.8 / 99.8 A 
pB27_A-13 5p 3p  AFAP1 var2 1458 1859 IF Sense 99.8 / 99.8 A 
pB27_A-63 5p 3p  AFAP1 var2 1464 1793 IF Sense 100.0 / 100.0 A 
pB27_A-53 5p 3p  AFAP1 var2 1503 1862 IF Sense 100.0 / 100.0 A 
pB27_A-74 5p 3p  AFAP1 var2 1503 1862 IF Sense 100.0 / 100.0 A 
pB27_A-17 5p 3p  AFAP1 var2 1521 1793 IF Sense 100.0 / 100.0 A 
pB27_A-21 5p  AFAP1 varA 1674 2125 IF Sense 100 D 
pB27_A-47 5p 3p  AFAP1 varA 1674 2125 IF Sense 100.0 / 100.0 D 
pB27_A-42 5p 3p  CREBZF 519 1225 х IF Sense 99.8 / 98.6 E 
pB27_A-51 5p 3p  EXOSC9 6 828 IF Sense 99.7 / 98.8 A 
pB27_A-56 5p 3p  EXOSC9 6 828 IF Sense 99.9 / 99.9 A 
pB27_A-39 5p 3p  EXOSC9 21 902 IF Sense 98.8 / 98.6 A 
pB27_A-1 5p 3p  EXOSC9 69 905 IF Sense 99.5 / 98.6 A 
pB27_A-12 5p  EXOSC9 69 No Data IF Sense 99.3 A 
pB27_A-45 5p 3p  EXOSC9 72 838 IF Sense 98.7 / 97.8 A 
pB27_A-62 5p 3p  FBXO28 -19 1015 IF Sense 97.8 / 97.1 B 
pB27_A-33 5p 3p  FBXO28 23 1052 OOF2 Sense 97.2 / 94.7 B 
pB27_A-57 5p 3p  FBXO28 23 1052 OOF2 Sense 99.6 / 96.2 B 
pB27_A-27 5p 3p  FBXO28 23 1052 OOF2 Sense 97.8 / 98.6 B 
pB27_A-46 5p 3p  GABARAP -85 577 *х IF Sense 100.0 / 99.0 A 
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pB27_A-34 5p 3p  GABARAP -85 577 *х IF Sense 100.0 / 99.1 A 
pB27_A-19 5p 3p  GABARAP -70 576 *х IF Sense 100.0 / 99.7 A 
pB27_A-66 5p 3p  GABARAP -67 469 *х IF Sense 100.0 / 98.2 A 
pB27_A-14 5p 3p  GABARAP -67 454 *х IF Sense 99.2 / 99.6 A 
pB27_A-22 5p 3p  GABARAP -55 577 *х IF Sense 99.8 / 98.6 A 
pB27_A-23 5p 3p  GABARAP -55 577 *х IF Sense 99.8 / 98.5 A 
pB27_A-60 5p 3p  GABARAP -46 571 *х IF Sense 100.0 / 99.0 A 
pB27_A-16 5p 3p  GABARAP -46 444 *х IF Sense 100.0 / 99.2 A 
pB27_A-50 5p 3p  GABARAP -37 578 *х IF Sense 99.8 / 100.0 A 
pB27_A-15 5p 3p  GABARAP -31 455 *х IF Sense 99.8 / 93.6 A 
pB27_A-44 5p 3p  GABARAP -31 455 *х IF Sense 99.8 / 97.6 A 
pB27_A-55 5p 3p  GABARAP -25 467 *х IF Sense 99.8 / 99.4 A 
pB27_A-11 5p  GABARAP -25 467 *х IF Sense 100 A 
pB27_A-36 5p 3p  GABARAP -22 579 *х IF Sense 100.0 / 98.0 A 
pB27_A-68 5p 3p  GABARAP -22 579 *х IF Sense 100.0 / 99.8 A 
pB27_A-59 5p 3p  GABARAP -19 367 *х IF Sense 100.0 / 98.7 A 
pB27_A-61 5p 3p  GABARAP -7 574 *х IF Sense 100.0 / 99.3 A 
pB27_A-64 5p 3p  GABARAP -7 574 *х IF Sense 100.0 / 99.8 A 
pB27_A-72 5p 3p  GABARAP -7 561 *х IF Sense 100.0 / 97.6 A 
pB27_A-54 5p 3p  GABARAPL1 3 486 IF Sense 100.0 / 100.0 D 
pB27_A-25 5p 3p  ODC1 234 813 х IF Sense 100.0 / 97.4 D 
pB27_A-26 5p 3p  PLK4 1152 2244 IF Sense 97.7 / 97.1 D 
pB27_A-65 5p 3p  PSMB1 405 836 х IF Sense 99.3 / 99.3 D 
pB27_A-31 3p  ZNF521 No Data 1483 ?? Sense 94.1 E 
pB27_A-30 3p  ZNF521 No Data 1483 ?? Sense 95.9 E 
pB27_A-7 5p 3p  ZNF521 120 1484 IF Sense 94.3 / 97.1 E 
pB27_A-2 5p 3p  ZNF521 120 1484 IF Sense 95.2 / 99.6 E 
pB27_A-18 5p 3p  ZNF521 123 983 IF Sense 98.4 / 97.9 E 
pB27_A-32 5p 3p  ZNF521 123 983 IF Sense 98.6 / 96.7 E 
pB27_A-71 5p 3p  ZNF521 141 973 IF Sense 96.1 / 91.5 E 
pB27_A-28 5p 3p  ZNF521 354 997 IF Sense 100.0 / 99.5 E 
pB27_A-41 5p 3p  ZNF521 378 988 IF Sense 100.0 / 98.4 E 
 
 
 
 
 
Table 7 – Y2H screen results. 
Type sequence indicates if the 5’ and/or 3’ sequences were available for prey 
identification.  Gene name indicates the best match from GenBank.  Start/Stop 
indicates the position of the 5p and 3p prey fragment ends, relative to the position 
of the ATG start codon.  % Id 5p/3p indicates the percent identity of the prey 
fragment sequences with the gene reference sequence.  PBS is the confidence of the 
interaction. 
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GABARAP staining with the antibody ab109364 shows GABARAP diffusely 
distributed throughout the cytosol, and also localizing to vesicles (Figure 17).  Cells 
staining with both A76 and ab109364 are questionable as to whether co-localization 
occurs (Figure 18).  The individual antibody staining resembles the single target 
staining but when the two filters are merged there is little yellow signal that would 
indicate a co-localization of the two proteins.  The two proteins localize to similar 
regions of the cell but better resolution imaging is needed to conclude co-
localization and interaction. 
3.3. Materials and Methods 
3.3.1. Yeast 2 Hybrid screen 
A commercial company, Hybrigenics (Paris, France), was enlisted to perform 
the Y2H screen and data analysis.  The PLN SEA module was used as the bait.  The 
prey in this screen was a library from HBMEC cells provided by the company 
(Schweitzer et al., 1997; Zilberfarb et al., 1997).  I provided template DNA in the 
form of the PLN SEA entry clone.  From this they cloned the SEA sequence into their 
bait expression vector.  The bait and prey vectors were separately transfected into 
either a or α mating type yeast.  Yeast mating resulted in diploid yeast containing 
both the bait and prey plasmids.  Instances where protein interaction between the 
bait and prey are present colonies grew and data for that prey was analyzed and 
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could indicate proteins that bind to the bait which in this instance is the PLN SEA 
module.  A more in depth method from Hybrigenics is as follows. 
“Yeast two-hybrid screening was performed by Hybrigenics Services, S.A.S., 
Paris, France (http://www.hybrigenics-services.com).  The coding sequence for the 
human PLN (aa 80-194) was PCR-amplified and cloned into pB27 as a C-terminal 
fusion to LexA (N-LexA-HSPG2 -C). The construct was checked by sequencing the 
entire insert and used as a bait to screen a random-primed Human Bone Marrow 
Endothelial Cells cDNA library constructed into pP6. pB27 and pP6 derive from the 
original pBTM116 and pGADGH plasmids, respectively (Bartel et al., 1993; Vojtek 
and Hollenberg, 1995).  111 million clones (12-fold the complexity of the library) 
were screened using a mating approach with Y187 (mata) and L40DGal4 (mata) 
yeast strains as previously described (Fromont-Racine et al., 1997). 71 His+ 
colonies were selected on a medium lacking tryptophan, leucine and HIS. The prey 
fragments of the positive clones were amplified by PCR and sequenced at their 5’ 
and 3’ junctions. The resulting sequences were used to identify the corresponding 
interacting proteins in the GenBank database (NCBI) using a fully automated 
procedure. A confidence score (PBS, for Predicted Biological Score) was attributed 
to each interaction as previously described (Formstecher et al., 2005). 
 The PBS relies on two different levels of analysis. Firstly, a local score takes 
into account the redundancy and independency of prey fragments, as well as the 
distribution of reading frames and stop codons in overlapping fragments. Secondly,  
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Figure 17 - Single target ICC staining. 
WiDr cells were  analyzed by indirect immunofluorescence at 100X magnification.  
Secondary  anti-mouse and anti-rabbit Alexa Fluor 488 conjugated antibodies were 
used.  A)PLN was labeled with anti-PLN domain I mouse monoclonal antibody, A76, 
at a 1:100 concentration.  B)GABARAP was labeled with an anti-GABARAP rabbit 
monoclonal antibody, ab109364, at a concentration of 1:1000. 
A 
B 
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Figure 18 - Co-localization by ICC. 
WiDr cells were  analyzed by indirect immunofluorescence at 100X magnification.  
Cells were probed for PLN with anti-PLN domain I mouse monoclonal antibody, 
A76, at a 1:100 concentration and secondarily labeled with anti-mouse Alexa Fluor 
488 conjugated antibodies (green).  Cells were probed for GABARAP  with and anti-
GABARAP rabbit monoclonal antibody, ab109364, at a 1:1000 concentration and 
secondarily labeled with anti-rabbit Alexa Fluor 647 conjugated antibodies (red).  A) 
and B) are representative images of the staining.  Co-localization is difficult to 
determine.  All scale bars are 15µm. 
Dapi PLN 
A 
GABARAP Merge 
B 
Dapi PLN 
GABARAP Merge 
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a global score takes into account the interactions found in all the screens performed 
at Hybrigenics using the same library. This global score represents the probability of 
an interaction being nonspecific. For practical use, the scores were divided into four 
categories, from A (highest confidence) to D (lowest confidence). A fifth category (E) 
specifically flags interactions involving highly connected prey domains previously 
found several times in screens performed on libraries derived from the same 
organism. Finally, several of these highly connected domains have been confirmed 
as false-positives of the technique and are now tagged as F. The PBS scores have 
been shown to positively correlate with the biological significance of interactions 
(Rain et al., 2001; Wojcik et al., 2002)." 
3.3.2. Immunocytochemistry 
WiDr cells were cultured in Dulbecco's Modified Eagle Medium with L-
glutamine and supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% 
(v/v) penicillin streptomycin.  Cell were fed twice a week and split at an 
approximate ratio of 1:6 as recommended by ATCC.  For staining cells were grown 
in 6-well tissue culture plates on standard glass coverslips for the staining 
procedure.  The cells were grown to approximately 60% confluence, when small 
clusters formed.  After that the media was removed and the cells were fixed and 
permeabilized with ice cold methanol for 30 minutes in -20°C.  The cells were 
briefly rinsed with phosphate buffered saline (PBS) and then blocked in 2.5% (w/v) 
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BSA in filtered PBS overnight at 4°C.  To stain PLN, the primary mouse antibody A76 
was used at a concentration of 1:100 (Whitelock et al., 1999).  To stain GABARAP 
the primary rabbit monoclonal ab109364 from Abcam was used at a concentration 
of 1:1000.  Primary antibodies were diluted in 2.5% (w/v) BSA in PBS and 
incubated overnight in 4°C.  The next day the antibody was removed and the cells 
were washed with PBS.  Secondary antibodies were incubated with the cells at a 
concentration of 1:400 for no less than one hour.  Two different secondary 
antibodies were used in this staining procedure, one tagged with Alexa Flour 488 
and another tagged with Alexa Fluor 647.  Stained cells were imaged at 100X on an 
oil objective with either a fluorescein isothiocyanate (Ex: 493nm Em:517nm) or a 
texas red (Ex: 555nm Em: 615nm) filter on the axioscope microscope in GRB-W 
using Metamorph software. 
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Chapter 4 
Discussion and Future work 
I have shown that overall residue conservation in the SEA modules of various 
proteins is low and is primarily in the first half of the sequence alignment.  The fold 
of the PLN SEA module is predicted to be similar to that of other SEA modules 
maintaiing the α/β sandwich.  The PLN SEA module does not autocleave and this 
may be due to sequence features or increased flexibility in the autocleavage region.  
Proteins that bind to the PLN SEA have been identified and some verification has 
been performed.  In the future more work needs to be done to better characterize 
the recombinant protein, verify and assess the contribution of binding protein to 
protein trafficking, and identify which residues are responsible for binding. 
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4.1. Folding and potential for binding 
 To examine the folding pattern of the SEA module, the predictive 
modeling software Phyre2 was used.  Multiple possible protein templates were 
returned with both a confidence score and the percent of matched sequence identity 
with the PLN SEA module.  The template with the highest confidence was used to 
create the PLN SEA model.  Phyre2 predicted the PLN SEA to fold similarly to other 
SEAs in an α/β sandwich like conformation, often found in RNA binding proteins 
(Figure 7) (Kranz et al., 1996).  The PLN SEA model is similar to that of the MUC1 
SEA module.  One difference between the two folds is that the PLN SEA has three β 
strands while the MUC1 SEA has four.  The sequence alignments show that most of 
the conservation is reserved to the first half of the protein sequence.  The high 
similarity, between the two SEA structures, shows that while the sequence 
conservation from figure 6 was not 100%, enough of the interactions remain to 
maintain the same fold.  This then begs the question: Is the fold enough to cause the 
PLN SEA module to autocleave in the manner that the MUC1 SEA module does even 
though the autocleavage sequence is different? 
4.2. Comparison of autocleavage in recombinant SEA modules 
Autocleavage analysis was performed on recombinantly expressed protein.  
The analysis of the proteins by Coomassie staining was inconclusive as to 
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autocleavage (Figure 8).  Only the PN protein sample showed induced protein in the 
size ranges possible for SEA monomers.  PC showed an induced protein band of 28 
kDa, twice the expected size.  This could be due to two copies of the PLN SEA being 
present in the expression plasmid.  Western blot confirmed the PLN SEA data from 
the Coomassie staining (Figure 10).  The PLN SEA band electrophoresed at a weight 
equal to that of the whole uncleaved recombinant protein.  Models of the 
autocleavage regions of MUC1 and PLN indicate that the reason the PLN SEA does 
not autocleave may be attributed to two properties: the sequence and the fold.  The 
analysis in chapter 2 shows the PLN SEA has a phenylalanine instead of a serine so 
there is no hydroxyl group is available to perform the N to O acyl rearrangement 
needed for the MUC1 SEA to autocleave (Figure 6) (Levitin et al., 2005).  The PLN 
SEA autocleavage model shows a longer and perhaps more flexible loop in between 
the two strands (Figure 11).  This loop may be necessary for the packing of bulky 
amino acids like the tryptophan and phenylalanine in the PLN autocleavage motif 
and may also contribute to a non-cleaving behavior. 
The predictions made in table 4 are based on sequence alignments and fold 
modeling.  An alignment of SEA modules that autocleave show a 100% conservation 
of a phenylalanine, glycine, and a serine.  The glycine and serine are those of the 
autocleavage motif.  Fold modeling showed the identified phenylalanine next to the 
sequence that cleaves.  The phenylalanine may apply pressure to the turn between 
the two β strands aiding in the ester formation and the resulting cleavage. 
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4.3. Binding proteins and their sub-cellular localization 
The Y2H screen identified many proteins capable of binding the PLN SEA 
module.  The most likely binding partners include AFAP1, EXOSC9, GABARAP, and 
FBXO28. 
AFAP1 is a 730 amino acid, approximately 81 kDa protein that is a substrate 
for SRC and PKC (Flynn et al., 1993; Qian et al., 1998, 2002).  It may play a role as an 
adaptor protein linking Src family members and other signaling proteins to actin 
filaments (Qian et al., 2000; Baisden et al., 2001). Phosphorylation sites that have 
been found at residues Y353, Y491, Y501, and S668.  Multiple transcript variants 
encoding different isoforms have been found.  Literature indicates it may play a role 
in regulating cell-matrix adhesions and cell migration during the development and 
progression of some cancers (Dorfleutner et al., 2007; Walker et al., 2007; Zhang et 
al., 2007).   
EXOSC9 is also called 75kD polymyositis/scleroderma autoantigen 1 
or exosome complex exonuclease RPR45p6.  It is a 439 amino acid protein that 
weighs approximately 49kD.  To present, we know that it is a component of the 
exosome 3'  5' exoribonuclease complex that degrades unstable mRNAs 
(Mukherjee et al., 2002; Liu et al., 2006; van Dijk et al., 2007).  EXOSC9 is 
subcellularly located in the cytoplasm, nucleus, and nucleolus.  pSORT noted KKXX-
like motif in the C-terminus (KRAA), which could function as an ER membrane 
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retention signal.  pSORT also predicted subcellular localization primarily in the 
cytoplasm and nucleus, but a small portion was also predicted to be vacuolar.  
EXOSC9 autoantibodies are markers for autoimmune diseases, including 
scleroderma, systemic lupus erythematosus and polymyositis (Allmang et al., 1999; 
Brouwer et al., 2002; Raijmakers et al., 2003). 
GABARAP is 117 amino acids long and weighs approximately14 kDa.  pSORT 
predicts GABARAP to localize in the cytoplasm, nucleus, and cytoskeleton.  
GABARAP binds neurotransmitter receptors by mediating interaction with the 
cytoskeleton (Wang et al., 1999; Nymann-Andersen et al., 2002).  Literature also 
suggests localization in the endomembrane system and a function in intracellular 
membrane trafficking and autophagy (Kittler et al., 2001; Kabeya et al., 2004; 
Nakamura et al., 2008; Kirkin et al., 2009).  GABARAP has been shown to have 
similar localization to calnexin in the ER and Sec23 at the ER exit site (Nakamura et 
al., 2008).  A role in tumorigenesis via its intracellular trafficking function in 
invasive ductal carcinomas, invasive lobular carcinomas, adenomas and thyroid 
cancers also has been suggested (Klebig et al., 2005; Roberts et al., 2009).   
FBXO28 forms Skp, Cullin, F-box containing complex (SCF complexes) to act 
as protein-ubiquitin ligases.  This protein is 368 amino acids long and weighs 
approximately 41kDa, but much less is published on this protein.  The protein 
degradation function of the SCF complexe makes FBXO28 less of a likely binding 
partner for the PLN SEA module. 
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GABARAP is interesting because PLN is processed through the secretory 
pathway and GABARAP is shown to be involved with the pathway through vesicle 
formation and binding.  The other three Y2H screen high confidence hits have 
cellular topological conflicts that point to the possibility of experimental artifacts 
related to the way the yeast two hybrid system works.   
Immunostaining was only performed on GABARAP of the potential binding 
proteins identified by Y2H.  The individual ICC staining matched the expected 
patterns (Figure 17).  PLN stained as punctate foci, similar to patterns expected of 
vesicles in the secretory pathway.  GABARAP stained like vesicles as well but also 
stained diffusely throughout the cell.  This matches information in the literature 
stating GABARAP is a cytosolic protein associated with vesicles (Wang et al., 2000; 
Kabeya et al., 2004; Nakamura et al., 2008).  While GABARAP is associated with 
vesicles, it may never be found on the inner leaflet of the endomembrane system 
and thus not have access to PLN during trafficking.  Co-localization by ICC staining 
was performed to study this.  Dual staining of PLN and GABARAP in WiDr cells was 
inconclusive (Figure 18).   The staining shows the two proteins are in the same 
regions of the cell but the resolution is not great enough to show protein-protein 
interactions.  Refinement of standard ICC methods or imaging on a confocal 
microscopy or electron microscopy might provide intracellular localization 
information.  Additionally protein complex immunoprecipitation could separately 
show protein binding. 
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4.4. Future Work 
4.4.1. Structural analysis 
In this work recombinant proteins were used to evaluate autocleavage of the 
PLN SEA module and to verify the autocleavage of the MUC1 SEA previously shown 
in the literature.  Further analysis of the recombinant protein will help to support 
the finding that the PLN SEA module does not autocleave and ensure that is not 
artifact of the method of making and collecting the protein.  Secondary structural 
analysis can be performed with circular dichroism.   This will exclude protein 
misfolding as the reason for the PLN SEA module not autocleaving.   Additionally 
tertiary structure analysis through the Protein Production Group (PPG) at MD 
Anderson Cancer Center can contribute more knowledge of the PLN SEA.  The PPG is 
a standalone entity within the Center for Biomolecular Structure and Function that 
studies 3D protein structure by X-ray crystallography, NMR, or biophysical assay, 
only requiring an expression plasmid for submission. 
4.4.2. Immunohistochemistry 
Thus far co-localization studies have not been definitive.  Further 
optimization of the staining protocol is needed to confirm co-localization of PLN and 
GABARAP.  Confocal microscopy could be used to increase resolution of imaging and 
can slices through the cell to confirm that the molecules are present in the same 
plane.  To complement standard co-localization a commercially available protein 
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binding assay called Duolink® proximity assay can be used in parallel.  Duolink® 
PLA® technology uses oligonucleotide labeled secondary antibodies to detect 
protein interactions within a 40nm distance of one another. 
4.4.3. Knockdown of PLN SEA module binding proteins 
Once PLN SEA binding proteins are confirmed, their contribution to PLN 
trafficking and secretion can be studied.  siRNA knockdown of candidate proteins 
should show whether these proteins are necessary for secretion or act to control the 
time spent in the secretory pathway.  A change in the amount of PLN secreted into 
the media can be measured after siRNA treatment to determine if the protein is 
required for successful secretion.  Additionally a pulse-chase experiment could be 
used to determine if binding proteins control the time spent in the pathway.  
4.4.4. Contribution of residues involved in binding 
Lastly, the role of the residues identified in chapter 2 as possibly being 
involved in binding should be examined.  Each residue could be changed 
individually to a hydrophilic amino acid and expressed within a small portion of the 
protein containing the SEA in mammalian cells.  The purpose would be to see if 
altering their hydrophobicity and possible the ability to bind other proteins would 
change the path or time for normal protein maturation and presentation. 
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I would also like to use mutational methods to change the autocleavage motif 
in the PLN SEA to try to induce autocleavage.  Initially I would replace the 
tryptophan in the GWVFV PLN sequence with a serine.  The introduction of the 
serine at this position should be enough to cause autocleavage if the mechanism 
alone described in chapter one if sufficient to cause autoproteolysis.  The 
phenylalanine could also be changed in combination with the tryptophan to restore 
the exact autocleavage motif from the MUC1.  I would like to see if changing the 
peptide sequence would be enough or if the longer loop between the β strands 
would still block autocleavage.  If autocleavage still does not occur then a 
phenylalanine could replace the tyrosine that sits where phenylalanine was shown 
to possibly play a role in autocleavage in chapter two. If autocleavage can be 
induced in the PLN SEA, I would like to the expression a small portion of PLN with 
the modified SEA to see if autocleavage alters the transfer of the protein from the ER 
to the Golgi or slows down the transfer.  It would also be interesting to see if 
autocleavage changes the composition of the carbohydrates added just before the 
SEA.                   
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